Právní předpis byl sestaven k datu 31.10.2025.
Zobrazené znění právního předpisu je účinné od 01.04.2025.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
č. 242/2018 Sb. - Čl. II
č. 194/2021 Sb. - Čl. II
č. 159/2022 Sb. - Čl. II
č. 228/2023 Sb. - Čl. II
č. 52/2024 Sb. - Čl. II
č. 176/2024 Sb. - Čl. II
č. 419/2024 Sb. - Čl. II
463
XXXXXXXX VLÁDY
ze dne 18. xxxxxxxx 2013
x xxxxxxxxx xxxxxxxxxx xxxxx
Xxxxx xxxxxxxx podle §44c xxxx. 1 zákona x. 167/1998 Xx., x xxxxxxxxxx xxxxxxx x o xxxxx xxxxxxxxx xxxxxxx xxxxxx, xx xxxxx xxxxxx x. 273/2013 Xx.:
§1
Xxxx nařízení stanoví
a) x příloze č. 1 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx I xxxxx Xxxxxxxx xxxxxx x omamných xxxxxxx1) x
2. dalších xxxxxxxx xxxxx, s xxxxx xx x xxxxxx xxxxxxx xxxxxx zneužívání xxxxx proto, xx xxxxxxxxxxxxx nebo nepřímo xxxxxxxx zdraví, xxxxxxxx xxxxxxx xxxxxxxxx xxx xx xxxxxxx povolení x xxxxxxxxx, xxxx xx z xxxxxx xxxxxx xxxxx xxxxxxxxxx, xxx léčivé xxxxxxxxx xxxxxxxxxx xxxx xxxxxx xxxxx byly xxxxxxxx x xxxxxxx pouze xx xxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx xxxx xx xxxxxxx xxxxxxx xxxx,
(xxxx xxx "seznam x. 1 xxxxxxxx xxxxx"),
x) v příloze č. 2 x xxxxxx xxxxxxxx xxxxxx
1. omamných xxxxx xxxxxxxxxx do Seznamu XX podle Xxxxxxxx xxxxxx x omamných xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx xxxx xxxxxx xxxxx xxxx xxxxxxxx v xxxxxxx xx xxxxxx xxxx žádanku bez xxxxxxxx modrým xxxxxx,
(xxxx xxx "xxxxxx x. 2 xxxxxxxx xxxxx"),
x) x příloze č. 3 x xxxxxx xxxxxxxx seznam
1. xxxxxxxx látek zařazených xx Seznamu XX xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx x
2. xxxxxxx omamných xxxxx, x xxxxx xx z xxxxxx xxxxxxx jejich zneužívání xxxxx xxxxx, xx xxxxxxxxxxxxx nebo xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxx x xxxxxxxxx obsahující xxxx xxxxxx látky xxxx xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxx v xxxxxxxx x zacházení,
(dále xxx "xxxxxx x. 3 xxxxxxxx látek"),
d) v příloze č. 4 x tomuto xxxxxxxx seznam
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx X xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) a
2. dalších xxxxxxxxxxxxxx xxxxx, u xxxxx xx x xxxxxx xxxxxxx jejich xxxxxxxxxx anebo proto, xx bezprostředně xxxx xxxxxxx ohrožují xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxx x xxxxxxxxx xxxxxxxxxx xxxx psychotropní xxxxx xxxx xxxxxxxxx xxxxx k xxxxxxxx xxxxxxxxx, xxxxxxxx a xxxxx xxxxxxxx terapeutickým xxxxxx xxxxxxxxx v xxxxxxxx x zacházení,
(dále xxx "seznam x. 4 xxxxxxxxxxxxxx látek"),
e) x příloze č. 5 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx látek xxxxxxxxxx xx Xxxxxxx II xxxxx Úmluvy x xxxxxxxxxxxxxx látkách x
2. xxxxxxx psychotropních xxxxx, x xxxxx je x důvodu xxxxxxx xxxxxx zneužívání anebo xxxxx, xx bezprostředně xxxx nepřímo ohrožují xxxxxx, xxxxxxxx umožnit xxxxxxxxx xxx xx xxxxxxx povolení k xxxxxxxxx, xxxx je x xxxxxx xxxxxx xxxxx zabezpečit, xxx xxxxxx xxxxxxxxx obsahující xxxx xxxxxxxxxxxx látky xxxx vydávány x xxxxxxx xxxxx xx xxxxxx nebo xxxxxxx xxxxxxxx modrým xxxxxx xxxxxxxxxx x levého xxxxxxx xxxx do xxxxxxx xxxxxxx xxxx,
(xxxx xxx "xxxxxx č. 5 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 6 x xxxxxx xxxxxxxx seznam xxxxxxxxxxxxxx látek xxxxxxxxxx xx Seznamu XXX xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx,
x) v příloze č. 7 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx do Xxxxxxx XX podle Xxxxxx x psychotropních xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, u xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx bezprostředně nebo xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxx xxxx xxxxxxx bez xxxxxxxx xxxxxx xxxxxx,
(xxxx xxx "xxxxxx č. 7 xxxxxxxxxxxxxx xxxxx"), x
x) x příloze č. 8 k xxxxxx xxxxxxxx xxxxxx xxxxxxxxx xxxxxxxxxx xx Xxxxxxx XXX xxxxx Xxxxxxxx úmluvy x xxxxxxxx xxxxxxx,
(xxxx xxx "xxxxxx x. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Toto nařízení xxxx xxxxxxxx v xxxxxxx se směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx 98/34/ES xx xxx 22. xxxxxx 1998 o xxxxxxx xxx poskytování xxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxxx x předpisů xxx xxxxxx xxxxxxxxxx společnosti, x xxxxxxx xxxxx.
(2) Xxxx nařízení xxxxxxxxxxx xxxxxxxxx předpisy Evropské xxxx xxxxxxxx se xxxxxxxxxx xxxxx3).
§3
Xxxx xxxxxxxx xxxxxx xxxxxxxxx dnem 1. xxxxx 2014.
Příloha č. 1 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 1 omamných xxxxx
| Xxxxxxxxxxx xxxxxxxxxx název | Xxxxxxxx xxxxx xxxxx IUPAC | Poznámka | 
| Acetorfin | (5R,6R,7R)-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-4,5-epoxy-6,14-ethenomorfinan-3-yl-acetát | |
| Acetyl-alfa-methylfentanyl | (RS)-N-[1-(2-fenyl-2-methylethyl)-4-pipendyl]acetanihd | |
| Acetylmethadol | (3RS)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát | |
| Alfacetylmethadol | (3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát | |
| Alfameprodin | (3RS,4RS)-3-ethyl-4-fenyl-1-methylpiperidin-4-yl-propanoát | |
| Alfamethadol | (3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol | |
| Alfa-methylfentanyl | N-{1-[(1RS)-2-fenyl-1-methylethyl]piperidin-4-yl}propananilid | |
| Alfa-methylthiofentanyl | N-{1-[(1RS)-1-methyl-2-(2-thienyl)ethyl]piperidin-4-yl}propananilid | |
| Alfaprodin | (3RS,4SR)-4-fenyl-1,3-dimethy piperidin-4-yl-propanoát | |
| Alfentanil | N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl}-N-fenylpropanamid | |
| Allylprodin | 3-allyl-4-fenyl-1-methylpiperidin-4-yl-propanoát | |
| Anileridin | ethyl-1-(4-aminofenethyl)-4-fenylpiperidin-4-karboxylát | |
| Benzethidin | ethyl-1-[2-(benzyloxy)ethyl]-4-fenylpiperidin-4-karboxylát | |
| Benzylmorfin | 3-(benzyloxy)-4,5α-epoxy-17-methylmorfin-7-en-6α-ol | |
| Betacetylmethadol | (3S,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát | |
| Beta-hydroxyfentanyl | N-{1-[(2RS)-2-hydroxyfenethyl]piperidin-4-yl}propananilid | |
| Beta-hydroxymethylfentanyl | N-{1-[(2RS)-2-hydroxyfenethyl]-3-methylpiperidin-4-yl}propananilid | |
| Betameprodin | (3RS,4RS)-3-ethyl-4-fenyl-1-methylpiperidin-4-yl-propanoát | |
| Betamethadol | (3S,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol | |
| Betaprodin | (3RS,4RS)-4-fenyl-1,3-dimethylpiperidin-4-yl-propanoát | |
| Bezitramid | 2,2-difenyl-4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1H-benzimidazol-1-yl)piperidino]butannitril | |
| Dextromoramid | 1-[(3S)-2,2-difenyl-3-methyl-4-morfolinobutanoyl]pyrrolidin | |
| Diampromid | N-[2-(N-fenethyl-N-methylamino)propyl]propananilid | |
| Diethylthiambuten | 3-(diethylamino)-1,1-di(2-thienyl)but-1-en | |
| Difenoxin | 1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylová xxxxxxxx | |
| Xxxxxxxxxxx | xxxxx-1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx | |
| Xxxxxxxxxxxxxx | (5X,6X,7X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx | |
| Xxxxxxxxxxxxx | 4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx | |
| Xxxxxxxxxxx | [2-(xxxxxxxxxxxxx)xxxxx]-2-xxxxxx-2,2-xxxxxxx-xxxxxx | |
| Xxxxxxxxxxxx | 6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx | |
| Xxxxxxxxxxxxxxxxxx | X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx | |
| Xxxxxxxxxx-xxxxxxx | xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx | Xxxxxxxxxxxxxxxxx | 
| Xxxxxxxxx | (6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx | |
| Xxxxxxxxxx | (6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx | |
| Xxxxxxx | xxxxxxxx (x.X.2X,3X5X)3-xxxxxxx-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, xxxx xxxxxx x xxxxxxxx, x xxxxxxx xx xxxxx xxxxxx xxxxxxx x xxxxxx | |
| Xxxxxxxxxxxxxxxxxxxxx | X-xxxxx-X,1-xxxxxxxx-3,3-xxx(2-xxxxxxx)-2-xxxxxxxxxxxx | |
| Xxxxxxxxxx | 1-[2-(xxxxxxxxxxxx)xxxxx]-2-(4-xxxxxxxxxxxx)-5-xxxxx-1X-xxxxxxxxxxxx | |
| Xxxxxxxxxx | xxxxx-4-xxxxx-1-[2-(2-xxxxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx | |
| Xxxxxxx x xxxxxx xxx léčebné xxxxxxx | Xxxxxxx z konopí xxxxxxxx x přípravě xxxxxxxx přípravků xx xxxxxxxxxxxxxxxx obsahem xxxxxxxxxxxxxxxxxxxx | |
| Xxxxxxxxx | 4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx | |
| Xxxxxxxxxxx | X-(1-xxxxxx-2-xxxxxxxxxxxxxxx)xxxxxxxxxxxx | |
| Xxxxxxxxx | (2XX,6X,11X)-3-xxxxxxxx-6,11-xxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx | |
| Xxxxxxxxxx | 17-xxxxxxxxxxxxxxxx-3-xx | |
| Xxxxxxxxxxx | xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx | |
| Xxxxxxxx | X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx | |
| Xxxxxxxxxx | xxxxx-4-xxxxx-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx | |
| Xxxxxxxxxx | 4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx | |
| Xxxxxxxxxxxxx | 4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx | |
| Xxxxxxxxxxx | 4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx | |
| Xxxxxxxxxxxxxxx | xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx | |
| Xxxxxxxxxxx | 6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx | |
| Xxxxxxxxxxx | xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx | |
| Xxxxxxxxxx | 2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx | |
| Xxxxxxx | xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xxxxxx)xxxxx]xxx}xxxxxx | |
| Xxxx - list | Kokový xxxx | |
| Xxxxxx | (1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxx | |
| Xxxxxxxxxx z xxxxxxxx | Xxxxxxxxxxx x xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx xxxxxxxx | |
| Xxxxxx xxxxxxx x xxxxxxxx | X xxxxxxxx xxxxx xxxxxx xxxxxxx x xxxxxxxx, která obsahuje 1 % látek xx xxxxxxx tetrahydrokanabinolů x splňuje xxxxxxxx xxxxxxxxxxx xxxxx xxxxxx x xxxxxx xxxxxxxxxxx xxxxxxx | |
| Xxxxxx xxx xxxxxxx xxxxxxx | ||
| Xxxxxxxxxxxxxxxxx | 1-xxxxx-2-[9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx | |
| Xxxxxxxxxxxxx | (9X,13X,14X)-3-xxxxxxx-17-xxxxxxxxxxxxxx | Xxxxxxxxxxxxxx xxxxxxxxxxxxxxx [(+)-3-xxxxxxx-17-xxxxxxxxxxxxxx] xx xxxxx ze xxxxxxx omamných látek xxxxxxxxx x této xxxxxxx | 
| Xxxxxxxxxxx | (3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx | |
| Xxxxxxxxxx | (9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx | Xxxxxxxxxxxxxx xxxxxxxxxxxx [(+)-3-xxxxxxx-17-xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx v xxxx xxxxxxx | 
| Xxxxxxxxx | (2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3-xxxxxxxxx-8-xx | |
| Xxxxxxxx | (6XX)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx | |
| Xxxxxxxx, meziprodukt | 4-(dimethylamino)-2,2-difenylpentannitril | |
| Methyldesorfin | 4,5α-epoxy-6,17-dimethylmorfin-6-en-3-ol | |
| Methyldihydromorfín | 4,5-epoxy-6,17-dimethylmorfínan-3,6-diol | |
| Metopon | 4,5-epoxy-3-hydroxy-5,17-dimethylmorfinan-6-on | |
| Moramid, meziprodukt | 2,2-difenyl-3-methyl-4-morfolinobutanová xxxxxxxx | |
| Xxxxxxxxxxxxxx | X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx | 3-Xxxxx xxxxxxxx | 
| Xxxxxxxxxxxxxxxxxx | X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx | 3-xxxxxxxxxxxxxxxxxx | 
| Xxxxxxxxxxx konopí xxx xxxxxxx xxxxxxx | xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxx xxx xxxxxxx xxxxxxx xxxxxxxxxx xxxxxxxx | |
| Xxxxxxxxxx | xxxxx-4-xxxxx-1-(2-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx | |
| Xxxxxx | 4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx | |
| Xxxxxx methobromid | 4,5α-epoxy-3,6α-dihydroxy-17,17-dimethylmorfin-7-en-17-ium-bromid | a xxxx xxxxxxxx xxxxxxx xx xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxx xxxxxx-X-xxxxx | 
| Xxxxxx-X-xxxx | 4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx | |
| Xxxxxxxxxxxxxxx | 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx | XXXX | 
| Xxxxxxx | 3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx | |
| Xxxxxxxxxx | 4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx | |
| Xxxxxxxxxxxxxx | 4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx | |
| Xxxxxxxxxxxxx | (9X,13X,14X)-xxxxxxxx-3-xx | |
| Xxxxxxxxxxx | 6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx | |
| Xxxxxxxxx | 4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxx | |
| Xxxxxxxxxx | 4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx | |
| Xxxxx | Xxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, xxxxxxx xxxxxx xxxxxx xx xxxxx xxx X4 xxxx XX2 | |
| Xxxxxxxx | 4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx | |
| Xxxxxxxx | (5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx | |
| Xxxxxxxxx | (5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx | |
| Xxxxxxxxxxxxxxxxx | X-(1-xxxxxxxxxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx | |
| Xxxxxxxxxx | xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx | XXXXX | 
| Xxxxxxxx | xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx | |
| Xxxxxxxx, xxxxxxxxxxx X | 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx | |
| Xxxxxxxx, xxxxxxxxxxx X | xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx | |
| Xxxxxxxx, xxxxxxxxxxx X | xxxxxxxx 4-fenyl-1-methylpiperidin-4-karboxylová | |
| Piminodin | ethyl-1-(3-anilinopropyl)-4-fenylpiperidin-4-karboxylát | |
| Piritramid | 1'-(3,3-difenyl-3-kyanpropyl)-4'-ureido-1,4'-bipiperidin | |
| Proheptazin | 4-fenyl-1,3-dimethylazepan-4-yl-propanoát | |
| Properidin | isopropyl-4-fenyl-1-methylpiperidin-4-karboxylát | |
| Racemethorfan | (9RS,13RS,14RS)-3-methoxy-17-methylmorfinan | |
| Racemoramid | (3RS)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on | |
| Racemorfan | (9RS,13RS,14RS)-17-methylmorfinan-3-ol | |
| Remifentanil | methyl-3-[4-(N-acetonylanilino)-4-(methoxykarbonyl)]piperidino]propanoát | |
| Sufentanil | N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid | |
| Tapentadol | 3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]fenol | |
| Thebain | 4,5α-epoxy-3,6-dimethoxy-17-methylmorfína-6,8-dien | |
| Thebakon | (5R)-4,5-epoxy-3-methoxy-17-methylmorfin-6-en-6-yl-acetát | |
| Thiafentanil | methyl 4-(N-(2-methoxyacetyl)anilin)-1-(2-thiofen-2-ylethyl)piperidin-4-karboxylát | A-3080, Xxxxxxx | 
| Xxxxxxxxxxxx | X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx | |
| Xxxxxxx | xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx | |
| Xxxxxxxxxxxx | (XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx | 
Xxxxxx xxxxxxx xxxxxxxx xxxxx uvedených x xxxxx xxxxxxx, xxxx xxxxxx a xxxxxx xxxxxxxx xxxxx xxxxxxxxx x tomto seznamu x xxxx xxxxxxxx xxxxx uvedených x xxxxx xxxxxxx, xxxxxx xxxx xxxxxxx, xxxxxx x xxxxx ve xxxxx xxxxxxxxx, xxx xxxx soli xxxxx xxxxxxxxx.
Příloha č. 2 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 2 xxxxxxxx xxxxx
| Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx | Xxxxxxxx název podle XXXXX | Xxxxxxxx | 
| Xxxxxxxxxxxxxxxxxxx | 4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx | |
| Xxxxxxxxxxxxxxxx | (1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx | |
| Xxxxxxxxxxxxx | 4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx | |
| Xxxxxxxxxxx | 4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx | |
| Xxxxxxxx | 4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx | |
| Xxxxxx | 4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx | |
| Xxxxxxxxxxx | 4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx | |
| Xxxxxxxxx | 4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx | |
| Xxxxxxxxx | 4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx | |
| Xxxxxxxx | X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx | 
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu, xxxx xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxxxx solí xxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx xx xxxxx případech, xxx xxxx soli xxxxx xxxxxxxxx.
Xxxxxxx x. 3 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 3 xxxxxxxx xxxxx
| Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x&xxxx;xxxxxx xxxxxx / xxxxxx xxxxx | Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx xxxxxx xxxxx | Xxxxxxxx xxxxx podle XXXXX | Xxxxxxxx | 
| Xxxxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxx | X-xxxxx-X-(1-xxxxxx-xxxxxxxxx-4-xx)-xxxxxxxx | XXX 73750 | 
| Xxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxx | ||
| Xxxxxxxxxxxxxxxx | Xxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxx-2-xxxxxx | |
| XX-7921 | 3,4-xxxxxxx-X-{[1-(xxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxxxxx | ||
| XX-237 | xxxxxxxxxx; 1-X-xxxxxxx-4- xxxxxxxxxxxxxxxxxx; | 1-[4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xx]xxxxx-1-xx | |
| XX-238 | 1-[2,6-xxxxxxxx-4-(3-xxxxxxxxx-2-xxxx)xxxxxxxxx-1-xx]xxxxxx-1-xx | ||
| Xxxxxxxxxxxxxxxxxxx | XXX-X; benzodioxole-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl-1-2H-1,3-benzodioxol-5-karboxamid | |
| Benzoylbenzylfentanyl | N-fenyl-N-(1-benzyl-piperidin-4-yl)benzamid | ||
| Benzoylfentanyl | fenylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]benzamid | |
| Benzylfentanyl | Benzyl-F; X4129 | X-xxxxx-X-[1 -(xxxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxx | |
| Xxxxxxxxxxxxxxxxxxxxx | Xxxxxx XxX | X-(1-xxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxx-2-xxxxxxxxxx | |
| Xxxxxxxxxx | X 4793x; X 47931X | 4-xxxx-X-(2-(xxxxxxxxxxxxx) xxxxxxxxxx) xxxxxxxx | |
| Xxxxxxx | Xxxxxxxxx | 3-{1-[1-(4-xxxxxxxxx)xxxxx]xxxxxxxxx-4-xx}-1X-xxxxxxxxxxxx-2-xx | |
| Xxxxxxxxxxx | 2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-5-xxxxx-xX-xxxxxxxxxxxx-1-xxxxxxxxx | ||
| 4-Xxxxxxxxxxxxxxxxxxxxx | 4-Xx-xXX | X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx | |
| Xxxxxxxxxxxxxxxxxxx | xxxxxxxxxxx-X; XX-X | X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx | |
| Xxxxxxxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx | ||
| Xxxxxxxxxxxxxxxx | X530 | 4-(4-xxxxxxxxxx)-2,2-xxxxxxx-1-(1-xxxxxxxxxxxx)-1-xxxxxxx | |
| Xxxxxxxxxx | 4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx | ||
| Xxxxxxxxxxxx-2-xxxxx xxxxxxxx | X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx | ||
| Xxxxxxxxxxxx-4-xxxxx xxxxxxxx | X-(4-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx | ||
| Xxxxxxxx | 4,4-xxxxxxx-6-(xxxxxxxxxx-1-xx)xxxxxx-3-xx | ||
| Xxxxxx | xxxxxxxxxxxxxx | 2-[2-[(4-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]-X,X-xxxxxxxxxxxxxxxx | |
| Xxxxxxxxxxxxxxxxx | 2-{2-[(2,3-xxxxxxx-1-xxxxxxxxxx-5-xx)xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xx}-X,X- xxxxxxxxxxxx-1-xxxx | ||
| Xxxxxxxxxx | 5-xxxxxx xxxxxxxxxxxxx; 5-xxxxxx xxxxxxxxxxxxxxxxxx | 2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-5-xxxxxx-1X-xxxxxxxxxxxx-1-xxxxxxxxx | |
| Xxxxxxxxxxxxxx | X-xxxxxxxxxxxxxxxxxxxxx | 2-(4-xxxxxxxxxxxx)-5-xxxxx-1-(2-(xxxxxxxxx-1-xx)xxxxx)-1X-xxxxx[x]xxxxxxxx | |
| Xxxxxxxxxxxx | 2-[(4-xxxxxxxxxxx)xxxxxx]-5-xxxxx-1-(2-xxxxxxxxxx-1-xxxxxxx)-1X-xxxxxxxxxxxxx | ||
| Xxxxxxx | (5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx | ||
| Xxxxxxxx xxxxxxxxx analog | butyrfentanyl | N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]-butanamid | |
| 3 -Xxxxxxxxxxxxxxxxxxxxx | β'-xxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-x]-3-xxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxx | 
| Xxxxxxxxxx | X,X-xxxxxxx-2-{2-[(4-xxxxxxxxxx)xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xx}xxxxxxxxx | ||
| 2’-Xxxxx-2-xxxxx-3-xxxxxxxxxxxxxx | X-(1-(2-xxxxxxxxxxxxx)-3-xxxxxxxxxxxxxxx-4-xx)-X-(2-xxxxxxxxxx)xxxxxxxxxxx | ||
| 4-Xxxxx-xxxxxxxxxxxxx | 4X-XX | X-(4-xxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx | |
| 4-Xxxxx-xxxxxxxxxxxxxxxxxxxxxxxxx | xxxx-xxxxxxxxxxxxxxxxxxxxxx- xxxxxxxx | X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxx-4-xx)-xxxxxxxxxxxxxxxxxxxxx | |
| 2-Xxxxxxxxxxxxx | Xxxxxxxxxxxxxxxxx | X-(2-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx | 2-XX, x-XX | 
| 3-Xxxxxxxxxxxxx | Xxxxxxxxxxxxxxxxx | X-(3-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx | 3-XX, x-XX | 
| 4-Xxxxxxxxxxxxxxxxxxxx | xxxx-xxxxxxxxxxxxxxxxxxxx; 4X-xxxxxxxxxxxxxxx | X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxxxx-4-xx)xxxxx-2-xxxxxxxxxx | |
| 4-Xxxxxxxxxxxxxxxxxxxxx | 4X-1XX | X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx | |
| 3-XxxxxxxxxxxxxxxxxXxxxxxxxx | xxxxx-xxxxxxxxxxxxxxxxxx- xxxxxxxx | X-(3-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx | |
| 2X-xxxxxxx | 2-[xx(xxxxx-2-xx)xxxxx]-1-[1-(2-xxxxxxxxxxx)-1X-xxxxxx-2-xx]xxxxx-1-xx | ||
| Xxxxxxx XX-17 | X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxx-xxxxx-2-xxxxxxxxxx | ||
| Xxxxxxxxxxxxxxx | XX-X; 2-xxxxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxx-2-xxxxxxxxxx | |
| (xxx)Xxxxxxx-X-xxxxxxxx N-benzyl xxxxxx | X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx | ||
| Xxxxxx | (5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx | ||
| 4-xxxxxxxxxxxxxxxxxxxx | 4-XX-XX; x-xxxxxxxxxxxxxx xxxxxxxx | X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxxxxxx | |
| Xxxxxxxxxxxxxxxx | 2-xxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxx | ||
| Xxxxxxxxx-X-47700 | 3,4-xxxxxxxX-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-(xxxxxx-2-xx)xxxxxxxx | ||
| Xxxxxxxxxxxx | X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xxxxx xxxx | ||
| Xxxxxxxx-xxxxxxxx | (4-xxxxxxxxx)-(1-(xxxxxxxxxxxxx)-4-xxxxxxx-4-xxxxxxxxxxxxxxxxxx)xxxxxxxx | ||
| Xxxxxxxxxxx | 1-[4-(3-xxxxxxx xxxxx)-1 -methylpiperidin-4-yl]propan-1-on | ||
| Konopí | S xxxxxxxx xxxxxx xxx xxxxxxx použití xxxxxxx x xxxxxxx x.&xxxx;1 | ||
| Xxxxxxxxxxxxxxxx | (2X)-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2-xxxxxxxxx | ||
| Xxxxxxxxxxxxxxxxxxxxx | Xxxxxxx-XxX | 2-xxxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx | |
| 4-Xxxxxxxxxxxxxxxxxxxx | 4-XxX-XX | X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx | |
| 2-Xxxxxxxxxxxxxxxxxxxx | x-xxxxxxxxxxxxxxxxxxxx | X-(2-xxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-xxxxxxxx | |
| 2-Xxxxxx-XX-237 | 2-xxxxxx-xxxxxxxxxx | 1-[2-xxxxxx-4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xx]xxxxx-1-xx | |
| 3,4-Xxxxxxxxxxxxx-X-47700 | 3,4-XXX-X-47700; 3,4-XXX-47700; XXX-47; XXX-47700 | X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxx[x][1,3]xxxxxx-5-xxxxxxxxxx | |
| α-Xxxxxxxxxxxxxx xxxxxxxxx analog | BF; X-X | 2-xxxxxx-X-xxxxx-X-[1-(1-xxxxxxxxxxx-2-xx)xxxxxxxxx-4-xx]xxxxxxxxxx | |
| 3 -XxxxxXxxxxxxxXxxxxxxxx | β'-xxxxxXxxxxxxxXxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-3-xxxxxxxxx-2-xxxxxx | |
| Xxxxxxxxxxxxxx | X,X-xxxxxxx-2-[2-[(4-xxxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]xxxxxxxxx | ||
| Xxxxxxxxxxx | X,X-xxxxxxx-2-[2-[(4-xxxxxxxxxxxx)xxxxxx]-5-xxxxxxxxxxxxxxxxx-1-xx]xxxxxxxxx | ||
| Xxxxxxxxxxxxx | 2-(4-xxxxxxxxxxxxx)-5-xxxxx-1-(2-(xxxxxxxxxx-1-xx)xxxxx)-1X-xxxxx[x]xxxxxxxx | ||
| XX-45 | 1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)xxxxxxxxx | ||
| X-xxxxxxxxxxxxxxxxxx | 2-[2-[(4-xxxxxxxxxxx)xxxxxx]-5-xxxxx-xxxxxxxxxxxx-1-xx]-X-xxxxx-xxxxxxxxx | ||
| X-xxxxxxxxxxxxxxxxxxxx | X-xxxxx-2-[2-[(4-xxxxxxxxxxxxxxx)xxxxxx]-5-xxxxx-xxxxxxxxxxxx-1-xx]xxxxxxxxx | ||
| X-xxxxxx X-47931X | X-xxxxxxxxxxxxxxxx | 4-xxxx-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx | |
| Xxxxxxxxxx | xxxxx 2-xxxxxxxxxxx-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx | ||
| X-XXXX; xxxxxxxxxxxxxxxxxxxxxxxx | 3-(4-xxxxxx-1-xxxxxxxxxxxxxxx-4-xx)xxxxx xxxxxx | ||
| XXxxxxxxxx | X-3217 | X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx | |
| Xxxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxx, PBN, 127X49 | 1-(4,4-xx(xxxxxxx-2-xx)xxx-3-xx-2-xx)xxxxxxxxx | |
| Xxxxxxxxxxxx | X,X-xxxxxxx-5-xxxxx-2-[(4-xxxxxxxxxxxx)xxxxxx]-1-X-xxxxxxxxxxxx-1-xxxxxxxxx | ||
| Xxxxxxxxxxxxxx | 5-xxxxx-2-[(4-xxxxxxxxxxxxx)xxxxxx]-1-(2-xxxxxxxxxx-1-xxxxxxx)xxxxxxxxxxxxx | ||
| Xxxxxxxxxx x&xxxx;xxxxxx | |||
| Xxxxxxxxxxxxxxxxxxxxxxx | XXX-X | X-(1-xxxxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxxxxxxx-2-xxxxxxxxxx | |
| Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | XXXX-xxxxxxxx; TMCP-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2,2,3,3-tetramethylcyklopropan-1- xxxxxxxxxx | |
| Xxxxxxxxxxxxxxx | 2-xxxxxxxxxxx fentanyl | N-(1-fenethylpiperidin-4-yl)-N-fenylthiofen-2-karboxamid | |
| 4-(Trifluormethyl) U-47700 | N-(2-(dimethylamino)cyklohexyl)-N-methyl-4-(trifluormethyl)benzamid | ||
| U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-48800 | 2-(2,4-dichlorfenyl)-N-(2-(dimethylamino)cyklohexyl)-N-methylacetamid | ||
| U-49900 | 3,4-dichlor-N-[2-(diethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-50488 | 3,4-dichlor-N-methyl-A-[2-(1-pyrrolidinyl)cyklohexyl] xxxxxxxxxxxxxx | ||
| X-51754 | 2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx | ||
| XxxxxxXxxxxxxxx | XXX, XX | X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; xxxxxxxx xxxxxxxxxx analog | 
Včetně xxxx xxxxxxxx xxxxx uvedených x této xxxxxxx xx xxxxx případech, xxx xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx č. 4 x xxxxxxxx vlády x. 463/2013 Sb.
Seznam x. 4 psychotropních xxxxx
| Xxxxxxxxxxx xxxxxxxxxx název (XXX) | Další xxxxxxxxxxx xxxxxxxxxx název xxxx xxxxx xxxxxx xxxxx | Xxxxxxxx xxxxx xxxxx XXXXX | Xxxxxxxx | 
| 1-(Xxxxxxxxxxxxxxxx)-2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-1X-xxxxxxxxxxxx-5-xxxxxxxxxx | |||
| (+)-Xxxxxxxx | XXX, LSD-25 | (+)-8β-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin | |
| 1-(2-(Methylamino)propanoyl)naftalen | AMAPN | 2-(methylamino)-1-(naftalen-1-yl)propan-1-on | |
| 1-(3-Trifluormethylfenyl)piperazin | TFMPP | 1-[3-(trifluormethyl)fenyl]piperazin | |
| 1-Nafýron | 1-naphyrone | 1-naftalen-1-yl-2-pyrrolidin-1-yl-pentan-1-on | |
| 1p-LSD, 1X-XXX | xxxxxxxxxxx xxxxxxxx 1-propionyl lysergové; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx- -6,6x,8,9-xxxxxxxxxxxxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx | ||
| 2,3-Xxxxxxxxxxxxxxxxxxx | 2,3-XXXX | 1-(2,3-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 2,3-Xxxxxxxxxxxxxxxxxxxxxxxxx | 2,3-XXXX | 1-(1,3-xxxxxxxxxxx-4-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 2,4,5-Xxxxxxxxxxxxxxxxxxxxx | 2,4,5-XXXX | ||
| 2,4,6-Xxxxxxxxxxxxxxxxxxx | XXX-6 | 1-(2,4,6-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx | |
| 2,4-Xxxxxxxxxxxxxxxxxxx | 2,4-XXXX | 1-(2,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| 2,4-Xxxxxxxxxxxxxxxxxxx | 2,4-XXXX | 1-(2,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 2',4'-Xxxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx | 2,4-XXXXX | 1-(2,4-xxxxxxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx | |
| 2,5-Xxxxxxxxx-4-xxxxxxxxxxxxxx | XXX | 1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx | |
| 2,5-Xxxxxxxxx-4-xxxxxxxxxxxx | XXX | 1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx | |
| 25X-XXXXx | 2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx | Xxxxx-36 | |
| 25X-XXXXx | 2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx | 2X-X-XXXXx | |
| 25X-XXX; 25X-XX2X; 2X-X-XXX, XXX-2X-X; Cimbi-21 | 2-(4-jod-2,5-dimethoxyfenyl)-N[(2-fluorfenyl)methyl]ethylamin | ||
| 25I-NBOH | 2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol | 2C-I-NBOH; Xxxxx-27 | |
| 251-XXXXx | 2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx | XXXXx-2X-X | |
| 2-Xxxxxxxxxxxxxxxx | 2-XXX | (XX)-1-(2-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 2X-X-XXX | 2X-X-XXX | 2-(4-xxxx-2,3,6,7-xxxxxxxxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxxxxx | |
| 2X-X | 2X-X | 2,5-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxx | XX-25 | 
| 2X-X | 2X-X | 2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx | |
| 2-Xxxxxxxxxxxxxxxxx | 2-XXX | (XX)-2-xxxxxxxxxxx-1-(2-xxxxxxxxxx)xxxxxx-1-xx | |
| 2-Xxxxxxxxxxxxxx | 2-XX | 1-(2-xxxxxxxxxx)xxxxxx-2-xxxx | |
| 2-Xxxxxxxxxxxxxxxxxxxx | 2-Xx-2'-Xxx-XXX, | 2-(2-xxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxxxxxxxx | |
| 2-Xxxxxxxxxxxxxxxxx | 2-XXX; 2-xxxxxxxxxxxxxxxxxxxx | X-xxxxx-1-(2-xxxxxxxxxx)xxxxxx-2-xxxx | |
| 2-Xxxxxxxxxxxxxxxx | 2-XXX | 1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| 2-Xxxxxxxxxxxxxxxxxx | 2-XXX | (XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx | |
| 2-Xxxxxxxxxxxxxxxxx | 2-XXX | 1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 2X-XXXXX; SGT-13 | 8-chinolinyl-3-[(4,4-difluoφiperidin-1-yl)sulfonyl]-4-methylbenzoát | ||
| 2-Chloramfetamin | 2-CA | 1-(2-chlorfenyl)propan-2-amin | |
| 2-Chlorethkathinon | 2-CEC | 1-(2-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 2-Chlormethamfetamin | 2-CMA | 1-(2-chlorfenyl)-N-methylpropan-2-amin | |
| 2-Chlormethkathinon | 2-CMC | 1-(2-chlorfenyl)-2-(methylamino)propan-1-on | |
| 2-Chlorpentedron | 2-CPD | 1-(2-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 2-MAPB | 1-(benzofuran-2-yl)-N-methylpropan-2-amin | ||
| 2-Methoxymethylon | N-methyl-bk-MMDA-2 | 1-(6-methoxy-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-on | |
| 2-Methylamfetamin | 2-MA | (2RS)-1-(2-methylfenyl)propan-2-amin | |
| 2-Methylethkathinon | 2-MEC | 2-(ethylamino)-1-(2-methylfenyl)propan-1-on | |
| 2-Methylmetamfetamin | 2-MMA | 1-(2-methylfenyl)-N-methylpropan-2-amin | |
| 2-Methylmetkathinon | 2-MMC | 2-(methylamino)-1-(2-methylfenyl)propan-1-on | |
| 2-Methyl-N,N-dimethylkathinon | 2-MDMC | 1-(2-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 2-Methyl-N-ethylnorpentedron | 2-MEAP | 2-(ethylamino)-1-(2-methylfenyl)-pentan-1-on | |
| 2-Methylthioamfetamin | 2-MTA | (2RS)-1-[2-(methylsulfanyl)fenyl]propan-2-amin | |
| 2-Pyrrolidin-3-methoxy-propiofenon | α-PPP-MeO; XXxXXX | 3-xxxxxxx-1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | |
| 3-(4-Xxxxxxxxxxxxxxxxxxxx)-1-xxxxxxxxxxx | Xxx High | [4-(hydroxymethyl)fenyl]-(1-pentyl-1H-indol-3-yl)methanon | |
| 3-(p-Methoxybenzoyl)-N-methylindol | (4-methoxyfenyl)(l -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx | ||
| 3',4'- Xxxxxxxxxxxxx-α-xxxxxx XXX | XXXXX | 1-(3,4-xxxxxxxxxxxxxxxxxx)-2-xxxxxx-2-xxxxxxxxxxxxxxxxxx-1-xx | |
| 3,4-Xxxxxxxxxxxxxxxxxx | 3,4-XXXX; | 1-(3,4-xxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| 3,4-Xxxxxxxxxxxxxxxxxxxx | 3,4-XXXX | xxxxxx (2X)-2-(3,4-xxxxxxxxxxxx)-2-[(2X)-xxxxxxxx-2-xx]xxxxxx | |
| 3,4-Xxxxxxx-X,X-xxxxxxxxxxxxxxxxxxxx-xxxxxxxx | 3,4-XXXXXXX | 2-(xxxxxxxxxxxxxxxxxxxxx)-1-(3,4-xxxxxxxxxxxx)xxxxxx-1-xx | |
| 3,4-Xxxxxxxxx-α-XXX | 3,4-XXxX-α-XXX | 1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx | |
| 3,4-Xxxxxxxxxxxxxxxxxxx | 3,4-XXXX | 1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| 3,4-Xxxxxxxxxxxxxxxxxxx | 3,4-XXXX | 1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 3,4-Xxxxxxxxxx-α-xxxxxxxxxxxxxxxxxxxxxx | 3,4-XXxX-α-XXX | 1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | |
| 3,4-Xxxxxxxxxxxxxxxxxxxxxxxx | XXXX | 1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | XXXX | 
| 3',4'-Xxxxxxxxxxxxx-α-xxxxxxxxxxxxxxxx-xxxxx | XXXXX | (XX)-1-(3,4-xxxxxxxxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxx-1-xx | |
| 3 ',4'-Xxxxxxxxxxxxx-α-XXX | XXXXX | 1-(3,4-xxxxxxxxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx | |
| 3 -Brommethkathinon | 3-BMC | (RS)-1-(3-bromfenyl)-2-(methylamino)propan-1-on | |
| 3-Ethylmethkathinon | 3-EMC | (RS)-2-methylamino-1-(3-ethylfenyl)propan-1-on | |
| 3F-Fenmetrazin | 3-FPM; XXX-593 | 2-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx | |
| 3-Xxxxxxxxxxxxxx | 3-XX | 1-(3-xxxxxxxxxx)xxxxxx-2-xxxx | |
| 3-Xxxxxxxxxxxxxxxxx | 3-XXX; 3-xxxxxxxxxxxxxxxxxxxx | X-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-2-xxxx; X-xxxxx-3-xxxxxxxxxxxxxx | |
| 3-Xxxxxxxxxxxxxxxx | 3-XXX | 1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| 3-Xxxxxxxxxxxxxxxxxx | 3-XXX | (XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx | |
| 3-Xxxxxxxxxxxxxxxxx | 3-XXX | 1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 3-Xxxxx-α-XXX | 3X-α-XXX; 3F-PVP | 1-(3-fluorfenyl)-2-(1-pyrrolidin)pentan-1-on | 3-Fluor-α-PVP | 
| 3-Hydroxyfenazepam | 3-HOP, XXXX, 3-oxyfenazepam, 3 -xx droxy xxxxxxxxx | 7-xxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | |
| 3-Xxxxxxxxxxxxxxxxxx | 3-XX-XXX; | 3-[1-(xxxxxxxxx-1-xx)xxxxxxxxxx] xxxxx | |
| 3-Xxxxxxxxxxxxxx | 3-XX | 1-(3-xxxxxxxxxx)xxxxxx-2-xxxx | |
| 3-Xxxxxxxxxxxxxxxx | 3-XXX | 1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| 3-Xxxxxxxxxxxxxxxxxx | 3-XXX | 1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx | |
| 3-Xxxxxxxxxxxxxxxxx | 3-XXX | 1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 3-Xxxxxxxxxxxxxx | 3-XXX | 1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 3-XXXX | 1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx | ||
| 3-Xxxxxxx eticyklidin | 3-MeO-PCE | N-ethyl-1-(3-methoxyfenyl)cyklohexan-1-amin | |
| 3-Methoxy xxxxxxxxxxx | 3-XxX-XXX | 1-[1-(3-xxxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx | |
| 3-Xxxxxxxxxxxxxxxxxxx | 3-XxXXX | 1-(3-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 3-Xxxxxx-4-xxxxxxxxxxxxxxxxx | 3-Xxxxxxxxxxxxxxx | 1-(4-xxxxx-3-xxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 3-Xxxxxxxxxxxxxxx | 3-XX | (2XX)-1-(3-xxxxxxxxxxx)xxxxxx-2-xxxx | |
| 3-Xxxxxxxxxxxxxxxxx | 3-XXX | 2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx | |
| 3-Xxxxxxxxxxxxxxxxxx | 3-XXX | 1-(3-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx | |
| 3-Xxxxxxxxxxxxxxxxx | 3-XXX | 2-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx | |
| 3-Xxxxxx-X,X-xxxxxxxxxxxxxxxx | 3-XXXX | 1-(3-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx | |
| 3-Xxxxxx-X-xxxxxxxxxxxxxxxxx | 3-XXXX | 2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)-xxxxxx-1-xx | |
| 3-Xxxxxxxxxxxxxxxxxxx | 3-XXX | (2XX)-1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx | |
| 4'-Xxxxx-4-xxxxxxxxxxxxxx | 4-XXX; x-X-4-xxxxxxxxxxxxxx | 5-(4-xxxxxxxxxx)-4,5-xxxxxxx-4-xxxxxx-2-xxxxxxxxxx | |
| 4'-Xxxxxx-X-xxxxxxxxxxxxxxxxxx | 4'-xxxxxx-XxXX | 1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxxxxxx)xxxxxx-1-xx | |
| 4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx | XXXX | (XX)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxx-1-xx)xxxxx-1-xx | |
| 4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx | 4'-xxxxxx-α-XxXX | 4-xxxxxx-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | |
| 4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx | 4'-xxxxxx-α-XXX; XXXX | (XX)-1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx | |
| 4'-Xxxxx-α-XXX | 4'-xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | |
| 4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxxxxxxx | 4-XxX-XXX | {3-[2-(xxxxxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx | |
| 4-Xxxxxxxxxxxxxxx | 4-XXX | 1-(4-xxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxxxxxxxxxxxxx | 4-XXX | (XX)-1-(4-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | Xxxxxxxxx | 
| 4-Xxxx-α-xxxxxxxxxxxxxxxxxxxxx | 4Xx-α-XXX | 1-(4-xxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx | |
| 4-Xxxx-α-xxxxxxxxxxxxxxxxxxxxx | 4Xx-α-XXX; pBPPP, 4Xx-XXX | 1-(4-xxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx | |
| 4-Xxxxxxxxxxxxxxxx | 4-XXX | 2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxxxxxxxxxxxxxx | 4-XXX | (XX)-2-xxxxxxxxxxx-1-(4-xxxxxxxxxx)xxxxxx-1-xx | |
| 4X-Xxxxxxxxxxx | 4-XXX | 2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx | |
| 4-Xxxxxxxxxxxxxx | 4-XX | 1-(4-xxxxxxxxxx)xxxxxx-2-xxxx | |
| 4-Xxxxxxxxxxxxx | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxx-1-xx | ||
| 4-Xxxxxxxxxxxxxxxx | 4-XXX | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxxxxxxxxxxxxxx | 4X-XXX; p-fluoroethylphenidate | ethyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát | |
| 4-Fluorkathinon | 4-FC | 2-amino-1-(4-fluorfenyl)-propan-1-on | |
| 4-Fluormethamfetamin | 4-FMA | (RS)-1-(4-fluorfenyl)-N-methylpropan-2-amin | |
| 4-Fluormethkathinon | 4-FMC | 1-(4-fluorfenyl)-2-(methylamino)propan-1-on | Flefedron | 
| 4F-MPH; 4-XXXX | Xxxxxx-2-(4-xxxxxxxxxx)-2-(2-xxxxxxxx)xxxxxx | 4X-XXX | |
| 4-Xxxxx-X-xxxxxxxxxxxxx | 4X-XXX | 2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxx-1-xx | |
| 4-Xxxxx-X-xxxxxxxxxxxxxx | 4X-XXX; 4-xxxxx-α-xxxxxxxxxx-xxxxxxxxxxx | 2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxx-X-xxxxxxxxxxxxxxxxxxxxx | 4X-XXX; 4X-XXX; 4F-NIPP | 1-(4-fluorfenyl)-2-(1-methylethylamino)pentan-1-on | |
| 4-Fluorpentedron | 4-FPD; 4-X-xxxxxxxxx | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx | 4-xxxxxx-α-XXX; 4X-XXX; X-2370 | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | |
| 4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxx | 4X-XXX | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx | |
| 4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx | 4X-α-XXX; 4X-XX8 | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | |
| 4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx | 4-X-α-XXX | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx | |
| 4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx | 4X-xxxxx-XXxX; 4F-α-PiHP | 1-(4-fluorfenyl)-4-methyl-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4-Fluor-α-pyrrolidinoktanofenon | 4F-α-POP; 4X-XX9 | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx | |
| 4X-XXXX-XXXX | xxxxxx (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx | ||
| 4X-XXXX-XXXXXX; 4X-XXX | xxxxxx (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx | ||
| 4-X-α-XXX xxxxxxxxx analog | 1-(4-fluorfenyl)-2-(1-piperidyl)pentan-1-on | ||
| 4-HTMPIPO | 4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on | ||
| 4-Hydroxy-N-methyl-N-ethyl tryptamin | 4-HO-MET | 3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol | Metocin; Xxxxxxxxxxx | 
| 4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx | 4-XX-XxXX | 3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx | Xxxxxxxx | 
| 4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx | 4-Xx-α-XXX | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | |
| 4-Xxxxxxxxxxxxxx | 4-XX | 1-(4-xxxxxxxxxx)xxxxxx-2-xxxx | XXX | 
| 4-Xxxxxxxxxxxxx | Xx5-4864, xxxxxxxxxxxxxx | 7-xxxxx-5-(4-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | |
| 4-Xxxxxxxxxxxxxxxx | 4-XXX | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxxxxxxxxxxxxxxxxxxx | 4-XXX; xxxxxxxxxxx, | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxxxxxxxxxxxxxxx | 4-XXX | 1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx | x-XXX \ | 
| 4-Xxxxxxxxxxxxxxxxx | 4-XXX | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | Xxxxxxxxx | 
| 4-Xxxxx-X,X-xxxxxxxxxxxxxxxx | 4-XXX; 4-XXXX | 1-(4-xxxxxxxxxx)-2-(X,X-xxxxxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxx-X-xxxxxxxxxxxxx | 4-XXX | 2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx | 4-Xxxxxxxxxxxxxxxxxx | 
| 4-Xxxxxxxxxxxxxx | 4-XXX | 1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx | 4-xxxxx-α-XXX | 1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx | |
| 4-XXXX | 4-XXXX | 1-(xxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxx | |
| 4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxx | 4-XxX-α-XXX; 4-XXXXX | 1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx | |
| 4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxxx | 4-XxX-α-XXX; 4-XxX-α-XX8 | 1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | |
| 4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx | 4-xxxxxxx α-XXX; 4-XxX-α-XX9 | 1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx | |
| 4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx | 4-XxX-α-XXX | 1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | |
| 4'-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx | 4'-Xxxxxxx-α-XXX; MOPPP | (RS)-1-(4-methoxyfenyl)-2-(1-pyrrolidinyl)propan-1-on | |
| 4-MA | |||
| 4-Methylbufedron | 4-Me-MABP | 2-(methylamino)-1-(4-methylfenyl)butan-1-on | |
| 4-Methylethkathinon | 4-MEC | 2-(ethylamino)-1-(4-methylfenyl)propan-1-on | |
| 4-Methylkathinon | Normefedron; 4-XX | 2-xxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxxxxxxxxxxxxxxx | 4-XXX | 1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx | |
| 4-Xxxxxxxxxxxxxxxxx | Xxxxxxxx | 2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxxx-X,X-xxxxxxxxxxxxxxx | 2-xxxxxxxxxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx | ||
| 4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx | 4-XXXX | 1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx | |
| 4-xxxxxx-X-xxxxxxxxxxxxxx | (4-XXX) | (±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 4-Xxxxxx-X-xxxxxxxxxxxxxxxxx | 4-XXXX | 2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx | |
| 4-Xxxxxxxxxxxxxxxxxxx | 4-XXX | (2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx | |
| 4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx | XXXX | (XX)-1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxx-1-xx | |
| 4-XXX | 1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx | ||
| 5 - Xxxxxxxxxxxxxxxx | 5-XXX | 5-(2-xxxxxxxxxxx)xxxxx | |
| 5-XXXx; xxxxxxx-α-XXX | 1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx | ||
| 5X-XXX48; 5X-XXXXXXX | X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx | ||
| 5Xx-XX-XXXXXX | X-[(2X)-1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx]-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx | ||
| 5Xx-XXXX-XXXXXX; 5Xx-XXX | xxxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx | ||
| 5-Xx-xxxxxx XXX 018 indazol xxxxxx | 5Xx-XXX-018; 5Xx-XXX-018-X, THJ-018 xxxxxx analogue | [1-(5-chlorpentyl)-1H-indazol-3-yl](naftalen-1-yl)methanon | |
| 5 -Xxxxxxxxxxxxxxxxxxxxxxxxxxxx | 5-XXXXX; XXXX | 1-(2,3-xxxxxxxxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | |
| 5-XXXX | 1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx | ||
| 5X-3,5-XX-XXXXXXXX; 5X-3,5-XX-XXXXXXX, XX-037 | X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-3-(4-xxxxxxxxxx)-1X-xxxxxxx-5-xxxxxxxxxx | ||
| 5X-5,3-XX-XXXXXXXX; 5X-XX-XXXXXXX | X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-5-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| 5X-XX-X7XXXX | X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx | ||
| 5X-XX-XXXXXX | X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| 5X-XXXXXX | X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx | ||
| 5X-XXX-XXXXXX | X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| 5X-XXX48 | X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| 5X-XXX57 | xxxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| 5X-XXXXXX | X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx | ||
| 5X-XXX-XXXX | xxxxxx (2X)-2-[[1-(5-xxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxxxxxxxxxx | ||
| 5X-XXX-XXXXXX; 5F-AMB | methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát | 5F-AMP | |
| 5F-A-P7AICA | N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-karboxamid | ||
| 5F-APP-PICA | N-(1-amino-1-oxo-3-fenylpropan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| 5F-APP-PINACA | N-(2-amino-1-benzyl-2-oxo-ethyl)-1-(5-fluorpentyl)indazol-3-karboxamid | ||
| 5F-CUMYL-PEGACLONE | 5-(5-fluorpentyl)-2-(1-methyl-1-fenylethyl)-pyrido[4,3-b]indol-1-on | ||
| 5F-EDMB-PINACA | ethyl 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx | ||
| 5X-XXX-XXXXXX | xxxxx 2-[[1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx | ||
| 5X-XXX-398; XX-2201; | (4-xxxxxxxxxxxxx-1-xx)[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-xxxxxxxx | ||
| 5X-XXXX-X7XXXX | xxxxxx-2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xx]xxxxxxxxx}-3,3-xxxxxxxx xxxxxxxx | ||
| 5X-XXXX-XXXX; | xxxxxx (S)-2-({[1-(5-fluorpentyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | ||
| 5F-MDMB-PINACA; 5X-XXX | xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx | ||
| 5X-XXXX-2 | 1-(5-xxxxxxxxxxx)-X-(xxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx | ||
| 5X-XX-22 xxxxxxx analog | chinolin-8-yl 1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| 5X-XX-22; 5F-QUPIC | 8-chinolinyl xxxxx xxxxxxxx 1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx | ||
| 5-X-xxxxxx-3-xxxxxxxxxxxxxxx | [1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxx-3-xx)xxxxxxxx | ||
| 5X-XX-XXXX | 1-(5-xxxxxxxxxxx)-3-(xxxxxxxxxx-1-xxxxxxxx)-1-X-xxxxx | ||
| 5X-XX-XXXXXX | [1-(5-xxxxxxxxxxx)xxxxxxx-3-xx]-xxxxxxxxxx-1-xx-xxxxxxxx | ||
| 5X-XXX-005 | xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| 5X-XXX-006 | X-xxxxxx-1-(5-xxxxxxxxxxx)-x X-xxxxx-3-xxxxxxxxxx | ||
| 5XXX-144 | [1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx | XXX-11 | |
| 5-XXXX | 1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx | ||
| 5-XxX-XXX | 5 -xxxxxxx-α-xxxxxxxxxxxxxxx | ||
| 5-XxX-XXXX | X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx | ||
| 5-XxX-XxXX | X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-xxxxxxxxxxxx-2-xxxx; 5-xxxxxxx-X-xxxxxx-X-xxx-xxxxxx tryptamin | ||
| 5-Methoxymethy Xxx | X-xxxxxx-xx-XXXX-5 | 1-(7-xxxxxxxxxxxx[x] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| 5-XXXx | 1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx | ||
| 6-XXX | 6-(2-xxxxxxxxxxx)xxxxxxxxxx | ||
| 6-XXXX | 1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx | ||
| 6-XXXX | 1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx | ||
| 7-XXXX | 1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx | ||
| X-796,260 | [1-(2-xxxxxxxx-4-xxxxxxx)-1X-xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx | ||
| X-796,260 xxxxxx | ((X)-1-(1-(2-xxxxxxx-1-xx)xxxxx)xxxxx-3-xx)-3,4,4-xxxxxxxxxxxx-2-xx-1-xx | ||
| X-834,735 | 1-(xxxxxxxxxxxxxxx-4-xxxxxxxx)-1X-xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx | ||
| X-836,339 | X-[3-(2-xxxxxxxxxxxx)-4,5-xxxxxxxx-1,3-xxxxxxx-2-xxxxxx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-xxxxxxxxxx | ||
| XX-005 | [1-[(1-xxxxxx-2-xxxxxxxxxxx)xxxxxx]-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)-xxxxxxxx | ||
| XX-005 azepan xxxxxx | (1-(1-xxxxxxxxxxxx-2-xx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx | ||
| XX-XXXXXXXX | X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XX-XXXXXXXX | X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-[(2-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XX-XXXXXXXXXX; | X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-3-(4-xxxxxxxxxx)-1X-xxxxxxx-5-xxxxxxxxxx | ||
| XX-XXXXXXXX | X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-x(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XX-XXXXXX | X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XX-XXXXXX | X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(2-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| Xxxxxxxxx-XXXXXXXX | X-(1-xxxxxxxxx)-1-(xxxxxxx xxxxxxxx-4-xxxxxxxx)xxxxxxx-3-xxxxxxxxxx | ||
| XXX-XXXXXXXX | X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx | ||
| XXX-XXXXXX | X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx | ||
| XXX-XXXXXXXX | X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxx-xxxx | ||
| XXXXXX | X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx | ||
| XXX-XXXXXX | X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-\X- xxxxxxx-3-xxxxxxxxxx | ||
| Xxxxxxxxxx | X 41123 | 1-(8-chlor-6-fenyl-4H-[1,2,4]tnazolo[4,5-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethan xxxx | |
| X-XXXXXXXX | X-(1-xxxxxxxxx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XXX-57 | Xxxxxxx-1-xx-1-xxxxxxxxxxxxx-3-xxxxxxxxxx | ||
| XX-XXX | (6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxx-9-xxxxxxxxxx | 6-xxxxx-6-xxx-XXX | |
| Xxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxx | (2-(3-(xxxxxxxxxxx)-5-xxxxxx-4-X-1,2,4-xxxxxxx-4-xx)-5-xxxxxxxxxx)(xxxxx)xxxxxxxx | ||
| XX-1220 | 1-[(1-xxxxxxxxxxxxxxx-2-xx)xxxxxx]-1X-xxxxx-3-xx}(xxxxxx)-xxxxxxxx | ||
| XX-1220 xxxxxx xxxxxx | 1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx] (xxxxxx)xxxxxxxx | ||
| XX-1248 | xxxxxxx-1-xx(1-((1-xxxxxxxxxxxxxxx-2-xx)xxxxxx)-1X-xxxxx-3-xx)xxxxxxxx | ||
| XX-1248 xxxxxx izomer | adamant-1-yl(1-(1-methylazepan-3-yl)-1H-indol-3-yl)methanon | ||
| AM-2201 | [1-(5-fluorpentyl)-1H-indol-3-yl] (xxxxxxxx-1-xx)xxxxxxxx | ||
| XX-2201 xxxxxxxxxxxx xxxxxx; XXXXXXXX | (1-(5-xxxxxxxxxxx)-1X-xxxxx[x]xxxxxxxx-2-xx)(xxxxxxxx-1-xx)xxxxxxxx | ||
| XX-2201 xxxxxxx karboxamid xxxxxx | X-1-xxxxxxxxxx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XX-2232 | 5-[3-(1-xxxxxxx)-1X-xxxxx-1-xx]xxxxxxxxxxxx | ||
| XX-2233 | 1-[(X-xxxxxxxxxxxxxxx-2-xx)xxxxxx]-3-(2-xxxxxxxxxx)xxxxx | ||
| XX-6527 | 1-xxxxxx-X-(xxxxxxxx-1-xx)-1X-xxxxx-3-xxxxxxxxxx | ||
| XX-6527 5-xxxxxxxxxxx xxxxxxx | 1-(5-xxxxxxxxxxx)-X-(xxxxxxxx-1-xx)-1X-xxxxx-3-xxxxxxxxx | ||
| XX-679 | (2-xxxxxxxx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx | ||
| XX-694 | 1-[(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(2-xxxxxxxx)xxxxxxxx | ||
| XX-694 (xxxxx xxxxxxxxx xxx) | 1-(5-xxxxxxxxxxx)-3-(2-xxxxxxxxxxxx)xxxxx | ||
| XX-694 (xxxxxx xxxxxxxxx xxx) | 1-(5-xxxxxxxxxxx)-3-(2-xxxxxxxxxxxxx)xxxxx | ||
| XX-694 chlor xxxxxxx | 1-[(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(2-xxxxxxxx)xxxxxxxx | ||
| XXX-4xx-XXXX | xxxxxx-3-xxxxxx-2-[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xxxxxxxxxxx]xxxxxxxx | ||
| XXX-XXXXXX | xxxxxx 2-[[1-[(4-fluorfenyl)methyl]indol-3-karboxamid]-3-methylbutanoát | ||
| AMB-FUBINACA; FUB-AMB | Methyl 2-({1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx | XXX-XXXXXXXX | |
| XXX-XXXXXX | Xxxxxx (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx | ||
| XXX-XXXxXXXX | xxxxxx 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamid)-3-methylbutanoát | ||
| APICA; XXX-001, 2XX1 | X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx | ||
| XXXXXXX | X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx | XXX48 | |
| XXX-XXXXXX | X-(1-xxxxx-1-xxx-3-xxxxxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XXX-XXXXXXXX | X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx | ||
| XXX-XXXXXXXX | X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-(xxxxxxxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx | ||
| xx-2X-X; βx-2X-X | 2-xxxxx-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xx | ||
| xx-XXX | 1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx | ||
| xx-XXXX | 1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxx-1-xx | ||
| xx-XXX | 2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx | ||
| XXXX | 2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxx-1-xx | ||
| XXXX; 3,4-XXXX | 2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx | ||
| Xxxxxxxxxxxxx | XXX | (2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx | |
| Xxxxxxxxxx | 8-xxxx-6-xxxxx-1-xxxxxx-4X-xxxxx[x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx | ||
| Xxxxx-Xxxxxxxxx | (2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx | ||
| Xxxxxxx | Xx-XXXX | 2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx | |
| XXX-018 | xxxxxxxx-1-xx 1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx | ||
| XX 47,497 | 2-[(1S,3R)-3-hydroxycyklohexyll-5-(2-methyloktan-2-yl)fenol | ||
| CP 47,497 (C8 + X2) | 2-((1X,3X)-3-xxxxxxxxxxxxxxxxx)-5-(2-xxxxxxxxxxx-2-xx)xxxxx; 2-((1S,3R)-3-hydroxycyklohexyl)-5-(dekan-3-yl)-fenol | 1,1-dimethyl a 1-xxxxx derivát C8-homologu | |
| CRA-13 | (naftalen-1-yl)[4-(pentyloxy)naftalen-1-yl]methanon | CB-13 | |
| CUMYL-4CN-B7AICA | 1-(4-kyanobutyl)-N-(2-fenylpropan-2-yl)-1H-pyrrol[2,3-b]pyridin-3-karboxamid | ||
| CUMYL-4CN-BINACA; XXX-78 | 1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx | ||
| XXXXX-5X-X7XXXX | 1-(5-x:xxxφxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx | ||
| XXXXX-5XXXXX | 1-(5-xxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx | ||
| XXXXX-5XXXXXXX | |||
| XXXXX-XXXX | 1-xxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx | ||
| XXXXX-XX-XXXXXXXXX | 5-(xxxxxxxxxxxxxxxx)-2-(1-xxxxxx-1-xxxxx-xxxxx)xxxxxx[4,3-x]xxxxx-1-xx | ||
| XXXXX-XXXXXXXXX; XXX-151 | 2-(1-xxxxxx-1-xxxxxxxxxx)-5-xxxxxx-xxxxxx[4,3-x]xxxxx-1-xx | ||
| XXXXX-XXXX | 1-xxxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx | ||
| XXXXX-XXXXXX | 1-xxxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XXXXX-XXXXXXXX | X-(2-xxxxxxxxxxx-2-xx)-1-((xxxxxxxxxx-2X-xxxxx-4-xx)xxxxxx)-1-X-xxxxxxx-3-xxxxxxxxxx | ||
| XXXX | 1,4-xxxxxxxxxxxxxxxxx | ||
| Xxxxxxxxxxxxxxxx | XXX-2; xxxxxxxx-2 | 2-xxxxx-9-xxxxxx-4-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx | |
| Xxxxxxxxxxxxxxx | 2-(xxxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx | ||
| Xxxxxxxx-X-xxxxx-xxxxxxx | X-XXX; 2-Xxx-XXX, xxxxxxxxxxxx | 2-(xxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx | |
| Xxxxxxxxx | Xx-XXXXX | 1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-1-xxxxxxx | Xxxxxxxxxxxxx | 
| Xxxxxxxxxx | 2-xxxxxxxxxxxxxx | 7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | Xx 5-3448 | 
| Xxxxxxxxxxxxxxxx | XXX | X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx] xxxx | |
| Xxxxxxxxx | XXX; 1,2-DEP; XXXX | 1-(1,2-xxxxxxxxxxxx)xxxxxxxxx | XX1X4X21 | 
| Xxxxxxxxxxxxx | Xx 07-4065 | 7-xxxxx-5-(2,6-xxxxxxxxxxxx)-1-xxxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx | |
| Xxxxxxxxxxxxxxxxxx | XXX | (2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx | |
| Xxxxxxxxxxxxxxxxxxxxxxx | XXXX | (2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx | |
| Xxxxxxxxxxxxxxxxxxxxxxx | XX-4662 | 1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | 2X-X-2 | [4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx | |
| Xxxxxxxxxxxxxxxxxxxxx | XXX, XXX | (2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx | |
| Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | 2X-X-7 | [4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx | |
| Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | XXXX | 3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx | |
| Xxxxxxxxxx | Xx-XXXXX | 1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx | 3,4-xxxxxxxxxxxxxxx- xxxxxxxxxxxxxx | 
| Xxxxxxxxxxxxxxxxx | XXX | X-[2-(xxxxx-3-xx)xxxxx]-X,X-xxxxxxxxxxxx | |
| Xxxxxxxxxx | 2-(xxxxxxxxxxxxx)-3΄,4΄-(xxxxxxxxxxxxx)xxxxxxxxxxxxx | 1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-xxxxxx-1-xx | |
| XXXX-XXXXXXXX | 2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx xxxxxxxx | ||
| XXX-2201 | [1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(4-xxxxx-xxxxxxxx-1-xx)xxxxxxxx | ||
| Xxxxxxxx | XXXXX; xxxxxxxxxx; EPE | N-ethyl-1,2-difenylethylamin | |
| EG-018 | naftalen-1-yl(9-pentyl-9H-karbazol-3-yl)methanon | ||
| EG-2201 | (9-(5-fluorpentyl)-9H-karbazol-3-yl)(naftalen-1-yl)methanon | ||
| EMB-FUBINACA | Ethyl 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx | ||
| Xxxxxxx | XXXXX; bk-EBDP | 1-(benzo[d] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx | X-xxxxx-xxxxxxxx | 
| Xxxxxxxxxxx | Xxxxxxxxxxxx; X-xxxxxxxxxxxxxx; ETH-CAT | 2-ethylamino-1-fenyl-propan-1-on | |
| ETH-LAD | (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindo1-[4,3-fg]chinolin-9-karboxamid | ||
| Ethylfenidát | (RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát | ||
| Ethylon | bk-MDEA | 2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on | |
| Ethyltenamfetamin | MDE, MDEA | (2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Eticyklidin | PCE | N-ethyl-1-fenylcyklohexylamin | |
| Etizolam | AHR3219; Xxxxx | 4-(2-xxxxxxxxxx)-2-xxxxx-9-xxxxxx-67/-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx | |
| Xxxxxxxxxx | 3-(2-xxxxxxxxxx)xxxxx | ||
| Xxxxxxx | xx-XXXX, X-Xxxxxxxxxxxxx | 1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx | |
| XXX-XX-22 | 1-xxxxxx 1-[(4-fluorfenyl)methyl]indol-3-karboxylát | ||
| Fenibut | phenibut | 4-amino-3-fenylbutanová xxxxxxxx | |
| Xxxxxxxxxxxxx | Xx 11-5073/000 | 8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx -4X- [1,2,4]xxxxxxx[4,3-x] [1,4]benzodiazepin | |
| Flubromazepam | 7-brom-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Flubromazolam | 8-brom-6-(2-fluorfenyl)-1-methyl-4H-[1,2,4]tnazolo-[4,3a] [1,4]xxxxxxxxxxxxx | ||
| Xxxxxxxxxxxxx | 2-xxxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x] [1,2,4]xxxxxxx[4,3-x] [1,4] xxxxxxxx | ||
| Xxxxxxxxxxxxx | 6-(2-xxxxxxxxxx)-1-xxxxxx-8-xxxx-4X-[1,2,4]xxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx | ||
| Xxxxxxxxx | Xx 05-4435 | 5-(2-fluorfenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-on | |
| FUB-144 | [1-[(4-fluorfenyl)methyl]indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| FUB-AKB48 | N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid | ||
| FUB-JWH-018 | (1-(4-fluorbenzyl)-1H-indol-3-yl)(naftalen-1-yl)methanon | ||
| FUB-NPB-22 | chinolin-8-y1-(4-fluorbenzyl)-1H-indazol-3-karboxylát | ||
| FUB-PB-22 | chinolin-8-yl-1-(4-fluorbenzyl)-1H-indol-3-karboxylát | ||
| Hexedron | β-propylmethcathinone | 2-(methylamino)-1-fenylhexan-1-on | |
| Hexylon | βk-MBDH | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)hexan-1-on | |
| HU-210 | (6aR, 10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloktan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | ||
| HU-331 | 3S,4R-p-benzochinon-3-hydroxy-2-p-mentha-(1,8)-dien-3-yl-5-pentyl | ||
| Hydroxytenamfetamin | (2R,S)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin | ||
| Indapyrofenidon | 1-(2,3-dihydro-1H-inden-5-yl)-2-fenyl-2-(pyrrolidin-1-yl)-ethanon | ||
| Ioddimethoxyfenethylamin | 2C-I | (4-iod-2,5-dimethoxyfenylethyl)amin | |
| Isohexedron | 4-methyl-2-(methylamino)-1-fenylpentan-1-on | ||
| Isopropylfenidát | IPPD | isopropyl2-fenyl-2-(2-piperidyl)acetát | |
| JTE-907 | N-(Benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydrochinolin-3-karboxamid | ||
| JWH 018 N-5-brompentyl derivát | [1-(5-brompentyl)-1H-indol-3-yl](naftalen-1-yl)methanon | ||
| JWH 018 N-5-chlorpentyl xxxxxxx | [1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx | ||
| XXX-007 | 1-xxxxxx-2-xxxxxx-3-(1-xxxxxxx)xxxxx | ||
| XXX-018 | (xxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx | ||
| XXX-018 xxxxxxxxxx xxxxxxx; | 1-xxxxxx-3-(xxxxxxx-1-xxx)xxxxx | ||
| XXX-018 xxxxxxxxxxxxxxx xxxxxxx | [1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx | ||
| XXX-018 | xxxxxxxx-8-xx-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx | ||
| XXX-018 xxxxxxx xxxxxx | 1-xxxxxxxxxx(1-xxxxxx-1X-xxxxxxx-3-xx)-xxxxxxxx | ||
| XXX-019 | 1-xxxxx-3-(1-xxxxxxx)xxxxx | ||
| XXX-022 | xxxxxxxx-1-xx(2-(xxxx-4-xxxx)-1X-xxxxx-3-xx)xxxxxxxx | ||
| XXX-030 | xxxxxxxx-1-xx(1-xxxxxx-1X-xxxxxx-3-xx)xxxxxxxx | ||
| XXX-071 | (1-xxxxx-1X-xxxxx-3-xx)-1-xxxxxxxxx 1-xxxxxxxx | ||
| XXX-073 | (1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx | ||
| XXX-073 xxxxxx xxxxxxx | 1-xxxxx-3-(1-(4-xxxxxx)xxxxxxx)xxxxx) | ||
| XXX-081 | (4-xxxxxxxxxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx | ||
| XXX-122 | (4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx | ||
| XXX-122 pentenyl 2-xxxxxxxxxxx xxxxxxx | (4-xxxxxxxxxxxxxx-1-xx)(2-xxxxxx 1-(pent-4-en-1-yl)-1H-indol-3-yl)methanon | ||
| JWH-122 xxxxxxxx derivát | (4-methylnaftalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-yl)methanon | ||
| JWH-145 | naftalen-1-yl(1-pentyl-5-fenyl-1H-pyrrol-3-yl)methanon | ||
| JWH-182 | 1-pentyl-3-(4-propyl-1-naftoyl)indol | ||
| JWH-200 | [1-(2-morfolinoethyl)-1H-indol-3-yl] (xxxxxxxx-1-xx)xxxxxxxx | ||
| XXX-203 | 2-(2-xxxxxxxxxx)-1-(1-xxxxxxxxxxx-3-xx)xxxxxxx | ||
| XXX-210 | (4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx | ||
| XXX-250 | 2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx | ||
| XXX-2501 2-xxxxxxxx-X-xxxxxx-xxxxxxxxx derivát | 1-(2-methylen-N-methylpiperidyl)-3-(2-methoxyfenylacetyl)indol | ||
| JWH-251 | 2-(2-methylfenyl)-1-(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-302 | 1-pentyl-3-(3-methoxyfenylacetyl)indol | ||
| JWH-307 | (5-(2-fluorfenyl)-1-pentylpyrrol-3-yl)-naftalen-1-ylmethanon | ||
| JWH-307 xxxx xxxxxxx | (5-(2-xxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx | ||
| XXX-368 | [5-(3-xxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx | ||
| XXX-370 | [5-(2-xxxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx | ||
| XXX-387 | 1-xxxxxx-3-(4-xxxx-1-xxxxxxx)xxxxx | ||
| XXX-398 | (4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx | ||
| XXX-412 | |||
| XXX-412 5-fluorpentyl xxxxxxx | (4-xxxxxxxxxxxxx-1-xx)[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx | ||
| XXX-xxxxxxxxxxxxxxxx-8-xxxxxxxxxx; XX-22 | xxxxxxxx-8-xx 1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx | ||
| Xxxxxxxx | (2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx | ||
| Xxxxxxxxxxxxx | xxxxxxxxxx; XXX 4550445 | 8-xxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxx[4,3-x] [1,4]benzodiazepin | |
| Klonazolam | 6-(2-chlorfenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| Kloniprazepam | 5-(2-chlorfenyl)-1-(cyklopropylmethyl)-7-mtro-1,3-dihydro-2H-[1,4]-benzodiazepin-2-on | ||
| LTI-701 | 1-(5-fluorpentyl)-N-fenyl-indol-3-karboxamid | ||
| LY2183240 | N,N-dimethyl-5-[(4-bifenyl)methyl]tetrazol-1-karboxamid | ||
| M5FPIC | methyl-1-(5-fluorpentyl)-1H-indol-karboxylát | ||
| MAM-2201 | 1-(5-fluorpentyl)-3-(4-methyl-naftoyl)indol | ||
| MAM-2201 xxxxxxxxxxx xxxxxxx | [1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](4-xxxxxx-xxxxxxxx-1-xx)-xxxxxxxx | ||
| XXX-XXXXXXXX | 2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx xxxxxxxx | ||
| XXXX | 1 -benzyl-4-methylpiperazin | ||
| MDA 19 | X-[(X)-(1-xxxxx-2-xxxxxxxx-3-xxxxxx)xxxxx]xxxxxxxx | ||
| XXXX | 5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx | ||
| XXXX-4xx-XXXXXX | (xxxxxx 3,3-xxxxxxxx-2-(1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxxxxx) butanoát) | ||
| MDMB-FUBICA | methyl 2-(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx | ||
| XXXX-XXXXXXXX | 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx | ||
| XXXX-XXXXXXX | xxxxxx 2-(9-(xxxxxxxxxxxxxxxx)-9X-xxxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx | ||
| XXXX-XXXXXX | X-[[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx]-3-xxxxxx-xxxxx, xxxxxx xxxxx | ||
| XXXX-XXXXX | xxxxxx 3,3-xxxxxxxx-2-(9-xxxxxx-9 H-karbazol-3-karboxamido)butanoát | ||
| MDPHP; 3,4-XXXXX | 1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx | ||
| Xxxxxxxxxxxx | (X)-5-(2-xxxxxxxxxx)-3-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxxx | (4-xxxxxxxxxxxxxxx-1-xx)-(1-xxxxxxxxxxx-3-xx)xxxxxxxx | ||
| Xxxxxxxx | 3,4,5-xxxxxxxxxxxxxxxxxxxxxx | ||
| Xxxxxxxxxxxxx | Xxxxxxxxxxxxxxxx, Xxxxxxxxxxxxxxx | 2-xxxxxxxxxxxxx-1-xxxxxxxxxxx-1-xx | |
| Xxxxxxxxxxxxx | xxxxxxxxxxxxxxxxx, | X-xxxxxx-1-(xxxxxxxx-2-xx)xxxxxx-2-xxxx | |
| Xxxxxxxxxxxxx | X-(2-xxxxxxx-xX-xxxxxxxxxxx)-5X,8X,11X,14X-xxxxxxxxxxxxxxxxx | ||
| Xxxxxxxxx | xx-XXXX | 1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| Xxxxxxxxxxxx | Xxxxxxx | (2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| Xxxxxxxxxxxx | XXX | 2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx | |
| xxxxxxxxxxxxx | XXX | 1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx | 2-XxX-xxxxxxxxx | 
| Xxxxxxxxxxxxxx | XXXx, 2-Oxo-3'-methoxy-PCPr | 2-(3-methoxyfenyl)-2-(propylamino)cyklohexan-1-on | |
| Methoxyamfetamin | PMA | (2RS)-1-(4-methoxyfenyl)propan-2-amin | |
| Methoxymetamfetamin | PMMA | 1-(4-methoxyfenyl)-N-methylpropan-2-amin | |
| Methoxytenamfetamin | MMDA | (2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin | |
| Methylaminorex | (±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin | ||
| Methylklonazepam | ID 690; XX-690; xxxxxxxxxxxxxxxx; Xx 05-4082; Xx 5-4082 | 5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx | |
| Xxxxxxxx | Xx-XXXX | 2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx | |
| Xxxxxxxxxxxxxxxxxx | XXXX | (2X,X)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx | |
| Xxxxxxxxxxxxxxxxxxxxx | XXX | X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx | |
| Xxxxxxxxx | Xxxxxxxxxxxxxxxxx | 4-(2-xxxxxxxxxx)-2-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx | |
| Xxxxxxxx | 4-XXX-xXx; XXX | (3-xxxxxxx-2-(xxxxxxxxxxx)-1-(x-xxxxx)xxxxxx-1-xx | |
| x-Xxxxxxxxxxxxxxxxxxx | xXXX | 1-(3-xxxxxxxxxx)xxxxxxxxx | |
| X-XXXXX | 1-(xxxxxxxxxxxxxxxx)-2-xxxxxx-xxxxx-3-xxxxxxxxxx | ||
| XX-18 | X-(xxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XX-XXXXXXXX | 1-xxxxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx 1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XXxX-2201 | xxxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxxx}-3-xxxxxxxxxxxxxx | ||
| X-(2-xxxxxxxxxxxx)-X-(1-xxxxxxxxxxx)-2-(1-xxxxxx-1X-xxxxx-3-xx)-4-xxxxxxx-xxxxxxxxxx | |||
| X,X-xxxxxxx-2-(1-xxxxxx-1X-xxxxx-3-xx)-4-xxxxxxx-xxxxxxxxxx | |||
| Xxxxxxxxxxxxxxxxx | Xxxxxxx | 1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | X-2482 | 
| X-xxxxxxxxxxxxx | X-xxxxxxxxxxxxxxxxx, XXX | 2-(xxxxxxxxxx)-1-xxxxxxxxxx-1-xx | |
| X-xxxxxxxxxxxxx | xxxxx-xxxxxxxxx, xxxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxx, XXXXX | 1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx | |
| XXX-xxxxx xxxxxx | xx-XXX; , bk-EABDI | 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)butan-1-on | |
| N-ethylbufedron | NEB | 2-(ethylamino)-1-fenylbutan-1-on | |
| N-ethylheptedron | Ethylheptedrone | 2-(ethylamino)-1-fenyl-heptan-1-on | |
| N-ethylhexedron | HEX-EN; Xxxxxxxxxxxxxx; Ethyl-Hex | 2-(ethylamino)-1-fenyl-hexan-1-on | |
| N-ethyl-isohexedron | NEiH | 2-(ethylamino)-4-methyl-1-fenylpentan-1-on | |
| N-ethylnorpentedron | N-ethylpentedron | 2-(ethylamino)-1-fenyl-pentan-1-on | α-ethylaminopentiofe-non | 
| Nifoxipam | 5-(2-fluorfenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-on | ||
| N-isopropylhexedron | NiPH; N-isopropylhexedron | 2-(isopropylamino)-1-fenylhexan-1-on | |
| N-isopropylpentedron | NiPP; XXX, 2-IPP | 2-(isopropylamino)-1-fenylpentan-1-on | |
| Nitrazolam | 1-methyl-8-nitro-6-fenyl-4H-[1,2,4]triazolo[4,3-a] [1,4]xxxxxxxxxxxxx | ||
| XX-2201, XXX-2201 | xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx | ||
| X-xxxxxx-2-xxxxxxxxxx | X-xxxxxx-2XX | 2,3-xxxxxxx-X-xxxxxx-1X-xxxxx-2-xxxx | XX-2XX | 
| X-xxxxxxxxxxxxxxx | 2-[xxxxxx(xxxxxx)xxxxx]-1-(4-xxxxxxxxxxx)xxxxxx-1-xx | ||
| Xxxxxxxxxxxxxx | X-xxxxxxxxxxxxxxxxxx, xxxxxxxx-xxxxxxxxxx, xxxxxxxxxxxxx, Xx 5-3367 | 7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-1,4-xxxxxxxxxxxxx-2-xx | |
| X-xxxxxxxxxxxxxxxxxx | X-xxxxxxxxxxxxxxx | 1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| x-Xxxxxxxxxxxxxx | 4-XxX-XXX | {3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx }xxxxxx | Xxxxxxxxxx | 
| x-Xxxxxxxxxxxxxxxxx | XXX | 3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx | |
| Xxx 27569 | 5-xxxxx-3-xxxxx-X-{2-[4-(1-xxxxxxxxxxx)xxxxx]xxxxx}-1X-xxxxx-2-xxxxxxxxxx | ||
| Xxx 27759 | 5-xxxxx-3-xxxxx-X-{2-[4-(xxxxxxxxxxxxx)xxxxx]xxxxx}-1X-xxxxx-2-xxxxxxxxxx | ||
| Xxx 29647 | 5-xxxxx-3-xxxxx-X-(1-xxxxxxxxxxxxxxxx-3-xx)-3X-xxxxx-2-xxxxxxxxxx | ||
| Xxxxxxxxx | 3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx | ||
| XX-22 xxxxxxx xxxxxx | xxxxxxxx-8-xx-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx | ||
| Xxxxxxxxx | 1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx | ||
| Xxxxxxxx | Xxxxxxxxxxxxxxxxxxxxxx; βx-XXXX | (±)-1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| x-Xxxxxxxxxxxxxxxxxxx | xXXX | 1-(4-xxxxxxxxxx)xxxxxxxxx | |
| x-Xxxxxx-4-xxxxxxxxxxxxxx | 4,4'-XXXX | 4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx | x4-XXXX | 
| Xxxxxxxxxx | XXX 48,098 | (4-xxxxxxxxxxxx)-[2-xxxxxx-1-(2-xxxxxxxx-4-xxxxxxx)xxxxx-3-xx]xxxxxxxx | |
| Xxxxxxxxxxxxxx | X-xxxxxxxxxxxxxxx; XX | 1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| Xxxxxxxx | X-xxxxxxxxxxxxxxxxxx; | 1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx | |
| Xxxxxxxx | Xxxxxxxxx | 3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx | |
| Xxxxxxxxxx | 3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx | ||
| XX8, α-XXXX | 1 -xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx | ||
| XX9, α-POP | 1 -fenyl-2-(pyrrolidin-1-yl)-1-oktan-1-on | ||
| Pyrazolam | 8-brom-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3 -x] [1,4]xxxxxxxxxxxxx | ||
| XXX-4 | (4-xxxxxxxxxxxx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx | ||
| XXX-4 xxxxx izomer | (2-methoxyfenyl)(l -pentyl-1H-indol-3-yl)methanon | ||
| RCS-4(C4) | 4-methoxyfeny1-(1-butyl-1H-indol-3-yl)methanon | ||
| Rolicyklidin | PHP, XXXX | 1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx | |
| Xxxxxxxxxx X | xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x] xxxxxxxxxx-7-xxxxxxxxxx | ||
| XXX-005 | xxxxxxxx-1-xx-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx | ||
| XXX-006 | X-xxxxxx-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx | ||
| XXX-006 X-xxxxx xxxxxx | 1-xxxxxx-X-xxxxx-1X-xxxxx-3-xxxxxxxxxx | ||
| XXX-135 | X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx | ||
| Xxxxxxxxxxxx | XXX | (2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx | |
| Xxxxxxxxxxxx | XXX | 1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx | |
| Xxxxxxxx | xXxXXX; XXXX | 1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxx-xxxxxxxxxx)xxxxxx-1-xx | |
| Xxxxxxxxxxxxxxxxxxx | XXX | Δ6x(10x)-, Δ6α(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-tetrahydrokanabinoly a xxxxxx xxxxxxxxxxxxx | |
| Xxxxxxxxxxxxxx | 7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xxxxx | ||
| XXX-2201 | 5X-XXX-018-X, | [1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx] (1 -xxxxxx)xxxxxxxx | |
| XX-XXX; 3',4'-xxxxxxxxxxxxxx-α-XXX | 2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxx-2-xx)xxxxx-1-xx | ||
| XX-XXX; 2-pyrrohdin-1-yl-1-tetralin-6-yl- hexan-1-on | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)hexan-1-on | ||
| TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on | ||
| trans-CP 47,497-X8 | 5-(1,1-xxxxxxxxxxxxx)-2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-xxxxx | ||
| Xxxxxxxxxxxxxxxxxxx | XXX | (2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx | |
| Xxxxxxxxxxxxxxxxxxx-2 | XXX-2 | (2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx | |
| XX-144(-2X); | [1-(pent-4-en-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon | ||
| UR-144 | (1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethylcyklopropyl)methanon | TMCP-018 | |
| UR-144heptyl xxxxxxx | (1-xxxxxx-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)-xxxxxxxx | ||
| XX-144X-(5-xxxxxxxxxxx) xxxxxxx | (1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx | ||
| XXX-597 | [3-(3-xxxxxxxxxxxxxx)xxxxx]-X-xxxxxxxxxxxxxxxxxx | ||
| XXX-754 | 6-xxxxxx-2-[(4-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxx-4-xx | ||
| X-15 | 4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx | ||
| X-18 | 4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx | ||
| XXX 55212-2 | (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morfolinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yljnaftalen-1-ylmethanon | ||
| α-PVP | 1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | ||
| α-PVT | 2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)pentan-1-on | ||
| α-Pyrrolidinohexanofenon | α-PHP | 1-fenyl-2-(pyrrolidin-1-yl)-1-hexan-1-on | |
| α-Pyrrolidinoisohexanofenon | α-ΡιΗΡ | 1-fenyl-4-methyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | |
| α-Piperidinbutiofenon | α-PipBP | 1-fenyl-2-(piperidin-1-yl)butan-1-on | |
| α-Pyrrolidinbutiofenon | α-PBP | 1-fenyl-2-(pyrrolidin-1-yl)butan-1-on | |
| α-Pyrrolidinbutiothiofenon | α-PBT | 2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)butan-1-on | |
| α-Pyrrolidinnonafenon | α-PNP; XX-10; alpha-pyrrolidi-nononaphenone | 1-fenyl-2-(pyrrolidin-1-yl)nonan-1-on | |
| α-Pyrrolidinpropiofenon | α-PPP | 1-fenyl-2-(pyrrolidin-1-yl)propan-1-on | |
| β-Keto-indanylmethylaminopropan | bk-IMP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(methylamino)propan-1-on | 
Včetně stereoizomerů xxxxxxxxxxxxxx xxxxx, xx xx výslovné výjimky, xxxxxxxxx x xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxxxxxxxxxxx mohou xxxxxxxxx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx, x xxxx x esterů xxxxxxxxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx ve xxxxx případech, xxx xxxxx xxxxxxxxx.
Xxxxxxx č. 5 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 5 xxxxxxxxxxxxxx xxxxx
| Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx | Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx obecný xxxxx | Xxxxxxxx název podle XXXXX | Xxxxxxxx | 
| Xxxxxxxxx | (2XX)-1-xxxxxxxxxxx-2-xxxx | ||
| Xxxxxxxxxx | xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) xxxxx]xxxxxxxxx | ||
| Xxxxxxxxxx | (2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx xxxxx-2-xx | ||
| Xxxxxxxxxxxxxxxxxxxxx xxxx | 2X-X | (4-xxxx-2,5-xxxxxxxxxxxxxxxxx)xxxx | |
| Xxxxxxxxxxxx | (2X)-1-xxxxxxxxxxx-2-xxxx | ||
| Xxxxxxxxxxx | XXX | 1-(1-xxxxxxxxxxxxxxx)xxxxxxxxx | |
| Xxxxxxxxx | 7-(2-{[(2XX)-1-xxxxxxxxxxx-2-xx]xxxxx}xxxxx)-1,3-xxxxxxxx-7X- xxxxx-2,6-xxxx | ||
| Xxxxxxxxxxx | 2-xxxxX-3-xxxxxxxxxxxxxx | ||
| Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
| Xxxxxxxxxxxxx | 5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx | ||
| XXX | xxxxxxxx 4-xxxxxxxxxxxxxxx | ||
| Xxxxxxxxxxxx | (2XX)-1-xxxxxxxxxxx-2-xxxx | ||
| Xxxxxxxxxxxxxxx | (2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx | ||
| Xxxxxxxxxxxxxxx | (2X)-2,6-xxxxxxx-X-[(2X)-1-xxxxxxxxxxx-2-xx]xxxxxxxxx | ||
| Xxxxxxxxxxx | 3-(2-xxxxxxxxxx)-2-xxxxxx-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx | ||
| Xxxxxxxxxx | 2-xxxxxxx-3-(2-xxxxxxxxxxx)-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx | ||
| Xxxxxxxxxxxx | (2X)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx | ||
| Xxxxxxxxxxxx xxxxxxxxx | (2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx | ||
| Xxxxxxxxxxxxx | xxxxxx-(2XX)-2-xxxxx-2-[(2XX)-xxxxxxxxx-2-xx]xxxxxx | ||
| Xxxxxxxxxxxx | xxxxxxxx 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx | ||
| Xxxxxxxxxx | xxxxx-9-XXX | Δ9-xxxxxxxxxxxxxxxxxxx (XXX) a xxxx xxxxxxxxxxxxx a xxxxxx | xxxx. (-)-xxxxx-Δ9-XXX | 
| Xxxxxxxx | (2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] xxxxxx-2xx | 
Xxxxxx xxxx xxxxx uvedených x xxxx xxxxxxx xx xxxxx případech, xxx xxxxxxxxx takových xxxx xx xxxxx.
Příloha x. 6 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 6 xxxxxxxxxxxxxx xxxxx
| Xxxxxxxxxxx xxxxxxxxxx název (XXX) x xxxxxx xxxxxx | Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx | Xxxxxxxx xxxxx podle XXXXX | Xxxxxxxx | 
| Xxxxxxxxxxx | xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx | ||
| Xxxxxxxxxx | xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxx | ||
| Xxxxxxxxxxxxx | xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx | ||
| Xxxxxxxxxxxxxxxx | XXX | xxxxxx-2-xx | xxxxx-xxxxxxxxxxxxx | 
| Xxxxxxxxxxx | (3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx | ||
| Xxxxxx | (+)-xxxxxxxxxxxxxxxx | (1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx | |
| Xxxxxxxxxxx | (2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx | ||
| Xxxxxxxxxxxxx | xxxxxxxx 5-xxxxx-5[(1XX)-1-xxxxxxxxxxx]xxxxxxxxxxx | 
Xxxxxx xxxx látek xxxxxxxxx x této skupině xx xxxxx xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx xx možná.
Příloha č. 7 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 7 xxxxxxxxxxxxxx xxxxx
| Xxxxxxxxxxx nechráněný název (XXX) x xxxxxx xxxxxx | Xxxxx mezinárodní xxxxxxxxxx xxxxx nebo obecný xxxxx | Xxxxxxxx název xxxxx XXXXX | Xxxxxxxx | 
| Xxxxxxxxxxxx | 5,5-xxxxxxxxxxxxxxxxxx kyselina | ||
| Alprazolam | 8-chlor-6-fenyl-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| Amfepramon | 2-(diethylamino)-1-fenylpropan-1-on | ||
| Aminorex | 5-fenyl-4,5-dihydrooxazol-2-amin | ||
| Barbital | 5,5-diethylbarbiturová xxxxxxxx | ||
| Xxxxxxxxxx | XX 718; QM 6008; Xxxxxxxxxx; | 5-xxxxx-1,3,6,7,8,9-xxxxxxxxx-2X-[1]xxxxxxxxxxx[2,3-x] [1,4]diazepin-2-on | |
| Benzfetamin | (+)-N-benzyl-N-(2-fenyl-1-methylethy)-N-methylamin | ||
| Benzylpiperazin | 1-benzylpiperazin | ||
| Bromazepam | 7-brom-5-(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Brotizolam | 2-brom-4-(2-chlorfenyl)-9-methyl-6H-thieno[3,2-ƒ][1,2,4]triazolo[4,3-a][1,4]diazepin | ||
| Butobarbital | 5-butyl-5-ethylbarbiturová xxxxxxxx | ||
| Xxxxxxxxx | XX-798; | 4-[[7-xxxx-5-(2-xxxxxxxxxx)-2-xxx-1,3-xxxxxxx-1,4-xxxxxxxxxxxxx-3-xx]xxx]-4-xxx-xxxxxxxx xxxxxxxx | |
| Xxxxxxxxxxx | 7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxx | 7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxxx | 8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx | ||
| Xxxxxxxxx | X-(1-xxxxxxxxxxxxxxxxx)xxxxxxxx | ||
| Xxxxxxxxxxxxx | 1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx | ||
| Xxxxxxxxxxxxxx | (±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx | ||
| Xxxxxxxxxxxxxxx | xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxx | ||
| Xxxxxxxxx | 7-Xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxxxxxxx | (2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx | ||
| Xxxxxxxxxxx | (±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx | ||
| Xxxxxxxxxxxx | 5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx | ||
| Xxxxxxxxxxx | (+)-1-xxxxx-2-[(2-xxxxxxxxx)xxxxx] xxxxxx | ||
| Xxxxxxxxxxx | 7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxxxx | 7-xxxxx-2-[2-(xxxxxxxxxxxx)xxxxx]-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| XX-xxxxxx | 7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| XX-xxxxxxxx | 10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx | ||
| Xxxxxxxxxxxxxxx | 7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx | ||
| Xxxxxxxxx | 7-xxxxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxxxxxxxxxx | ||
| Xxxxxxx | (2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx | ||
| Xxxxxxxxx | 11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-4,7(6X)-xxxx | ||
| Xxxxxxxx | 7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxxx-2,4(3X,5X)-xxxx | ||
| Xxxxxxxxxx | 5-(2-xxxxxxxxxx)-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxxxx | 7-xxxxx-5-xxxxx-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx | ||
| Xxxxxxxxxxx | 5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx | ||
| Xxxxxxxxxx | 10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx | ||
| Xxxxxxxxx | XXX | (-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx | |
| Xxxxxxxxxx | 6-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X-xxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx | ||
| Xxxxxxxxx | 7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxxxxxx | 7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxx | 5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2.1-α]-xxxxxxxx-5-xx | ||
| Xxxxxxxxx | 7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx | ||
| Xxxxxxxxx | (±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx | ||
| Xxxxxxxxxx | 2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx | ||
| Xxxxxxxx | X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx | ||
| Xxxxxxxxxxxxxxxxxx | 5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx kyselina | ||
| Methyprylon | 3,3-diethyl-5-methylpiperidin-2,4-dion | ||
| Midazolam | 8-chlor-6-(2-fluorfenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin | ||
| Nimetazepam | 5-fenyl-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Nitrazepam | 5-fenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Nordazepam | 7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Oxazepam | 7-chlor-5-fenyl-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Oxazolam | 10-chlor-11b-fenyl-2-methyl-2,3,7,11b-tetrahydrooxazolo[3,2-d] [1,4]xxxxxxxxxxxxx-6(5X)-xx | ||
| Xxxxxxx | 5-xxxxx-2-xxxxx-1,3-xxxxxxxxxx-4-xx | ||
| Xxxxxxxxx | 7-xxxxx-5-xxxxx-1-(xxxx-2-xx-1-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxxx | xxxxxxx(2-xxxxxxxxx)xxxxxxxx | ||
| Xxxxxxxx | 7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxxxxx | (+)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx | ||
| Xxxxxxxxxxxxxxx | 5-xxxxx-5-(1-xxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx | ||
| Xxxxxxxxx | (XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxxxx | 7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx | ||
| Xxxxxxxxx | Xxxxxxxxx, Emandaxin, EGYT 341 Xxxxxxxxx, Xxxxxx, XX | 1-(3,4-xxxxxxxxxxxxxx)-5-xxxxx-7,8-xxxxxxxxx-4-xxxxxx-5X-2,3-xxxxxxxxxxxxx | |
| Xxxxxxxxx | 8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx | ||
| Xxxxxxxxxx | 5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx xxxxxxxx | ||
| Xxxxxxxx | X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxx[1,2-x]xxxxxxx-3-xxxxxxxx | 
Xxxxxx xxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x&xxxx;xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxx mohou xxxxxxxxx.
Xxxxxxx č. 8 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 8 vybraných xxxxxxxxx
| Xxxxxxxxx xxxxxxxxxx: | Xxxxxxxx: | ||
| 1) | xxxxx x xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx | Xxxxx obsahovat xxxxx nebo xxxx xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxx) a xxxxxxxx xxxxxx xxxxx | |
| x) | x xxxxx tabletě, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx lékové xxxxx xxxxx xxxxxxxxxx 100 xx, | ||
| x) | x xxxxxxx xxxxx být xxxxxxxxxxx xxxxx než 2,5 % | ||
| 2) | xxxxxxxxx | x) | Xxxxxxxx difenoxinu xxxxx xxxxxxxxxx v jedné xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v xxxx xxxxxx formě 0,5 mg. | 
| b) | Množství xxxxxxx-xxxxxxx xxxx xxx nejméně 5 % x xxxxxxxx difenoxylátu v xxxxx tabletě, kapsli, xxxxxx, xxxxx, xxxx. xxxx xxxxxx xxxxx. | ||
| 3) | xxxxxxxxxxx | x) | Xxxxxxxx xxxxxxxxxxxx nesmí přesáhnout x jedné tabletě, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx formě 2,5 xx. | 
| x) | Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx xxxxxxx 1 % x xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, tobolce, ampuli, xxxxx, xxxx. x xxxx xxxxxx xxxxx. | ||
| 4) | xxxxxxxxxxxxxxxx | Xxxxxxxx xxxxxxxxxxxxxxxxx | |
| x) | xxxxx xxxxxxxxxx 135 xx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx. | ||
| x) | x xxxxxxx nesmí xxx xxxxxxxxxxx xxxxx xxx 2,5 %. | ||
| Přípravek xxxxx xxxxxxxxx xxxxxx xxxxxxxxxxxx xxxxx. | |||
| 5) | xxxxxx | Xxxxxxxx xxxxxxx nesmí xxxxxxxxxx 0,1 % xxxxxxx. | |
| 6) | xxxxx xxxx xxxxxx | x) | Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,2 %. | 
| x) | Xxxx xxxxx xxxxxxxxx xxxxx xxxx xxxx xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxx). | ||
| Xxxxxx xxxxx v přípravku xxxxxxxx nesmí xxx xxxxxx xxxxxxx xxxx x xxxxxxx xxxxxxxx, xxx xxxxxxxx xxxxxxx xxxxxx | |||
| 7) | xxxxxxxxxxxxx prášek s xxxxx | x) | Xxxxxxxx xxxx x xxxxxx xxxxx xxx xxxxx xxx 10 %. | 
| x) | Xxxxxxxx ipekakuanhového xxxxxx xxxxx xxx xxxxx xxx 10 %. | ||
| c} | Množství xxxxx xxxx xxxx xxxxxxx xxxxx (nikoliv xxxx xxxxxxxxx) xxxxx xxx xxxxx xxx 80%. | ||
| 8) | xxxxxxxxx | x) | Xxxxxxxxx propiramu xxxxx xxxxxxxxxx 100 xx x xxxxx tabletě, xxxxxxx, ampuli, xxxxx, xxxx. x jiné Xxxxxx xxxxx. | 
| x) | Xxxxxxxxx xxxxxxxxxxxxxx x přípravku xxxx xxx xxxxxxx stejné xxxx xxxxx xxx xxxxxxxxx. | ||
Xxxxxx homeopaticky xxxxxxxxxx xxxxxxxxx, xxxxxxx stupeň xxxxxx xx xxxxx xxx X4 xxxx XX2.
Xx. II
Toto xxxxxxxx xxxx xxxxxxxx v xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 o xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx právním předpisem x. 46/2017 Sb. x xxxxxxxxx xx 1.3.2017
Čl. XX
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 xx xxx 9. xxxx 2015 o xxxxxxx při xxxxxxxxxxx xxxxxxxxx v xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx služby xxxxxxxxxx společnosti.
Čl. XX xxxxxx právním xxxxxxxxx x. 30/2018 Sb. x xxxxxxxxx xx 8.3.2018
Xx. XX
Xxxx nařízení xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx pro služby xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 242/2018 Xx. x xxxxxxxxx xx 25.10.2018
Xx. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx bylo xxxxxxxx x souladu se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 ze xxx 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx technických xxxxxxxx x předpisů pro xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx právním xxxxxxxxx x. 184/2021 Xx. x xxxxxxxxx xx 3.6.2021
Xx. XX
Xxxxxxxxx předpis
Toto xxxxxxxx bylo oznámeno x souladu se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx právním xxxxxxxxx x. 159/2022 Xx. x xxxxxxxxx xx 1.7.2022
Xx. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx bylo xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 ze xxx 9. září 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx v xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx č. 228/2023 Xx. x účinností xx 1.8.2023
Xx. II
Technický xxxxxxx
Xxxx xxxxxxxx bylo xxxxxxxx x xxxxxxx xx xxxxxxxx Evropského parlamentu x Xxxx (XX) 2015/1535 ze xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx technických předpisů x xxxxxxxx pro xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx právním xxxxxxxxx č. 52/2024 Xx. x účinností xx 6.3.2024
Čl. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x souladu xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Rady (XX) 2015/1535 ze xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x předpisů xxx xxxxxx informační společnosti.
Čl. XX vložen xxxxxxx xxxxxxxxx x. 176/2024 Xx. s xxxxxxxxx xx 1.7.2024
Xx. XX
Xxxxxxxxx předpis
Toto xxxxxxxx bylo oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (XX) 2015/1535 xx xxx 9. září 2015 x xxxxxxx xxx xxxxxxxxxxx informací x xxxxxxx xxxxxxxxxxx xxxxxxxx x předpisů xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX vložen xxxxxxx xxxxxxxxx x. 419/2024 Xx. x xxxxxxxxx xx 1.1.2025
Xxxxxx xxxxxxx x. 463/2013 Sb. xxxxx xxxxxxxxx xxxx 1.1.2014.
Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx xxxx xxxxxxxxxx xxxxx a xxxxxxxx xxxxxxxxxxx právním xxxxxxxxx x.:
243/2015 Sb., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx
x xxxxxxxxx xx 1.10.2015
46/2017 Xx., xxxxxx se mění xxxxxxxx vlády x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxx xxxxx x. 243/2015 Xx.
x xxxxxxxxx od 1.3.2017 x výjimkou xxxxxxxxx xxxxxxxxxx, která xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., xxxxxx se xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 8.3.2018
242/2018 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Sb., o xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 25.10.2018
184/2021 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 3.6.2021
159/2022 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 1.7.2022
228/2023 Xx., xxxxxx xx mění xxxxxxxx vlády x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.8.2023
52/2024 Xx., kterým xx xxxx xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek, ve xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx se xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.7.2024 x 1.1.2025
419/2024 Xx., xxxxxx se xxxx xxxxxxxx xxxxx x. 463/2013 Sb., x seznamech návykových xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.1.2025 x 1.4.2025
Xxxxx jednotlivých xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, pokud xx xxxx xxxxxx xxxxxxxxx změna xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.
1) Xxxxxxxx úmluva x xxxxxxxx látkách, xxxxxxxxx xxx č. 47/1965 Sb., xx znění Protokolu x xxxxxxx Xxxxxxxx xxxxxx x omamných xxxxxxx, xxxxxxxxxxx pod č. 458/1991 Sb.
Xxxxxxxx Komise v xxxxxxxxx xxxxxxxxx (EU) 2022/1326 xx xxx 18. xxxxxx 2022, xxxxxx xx mění xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX, xxxxx xxx o xxxxxxxx xxxxxx psychoaktivních látek xx definice xxxxx.
2) Úmluva o xxxxxxxxxxxxxx xxxxxxx, vyhlášená xxx č. 62/1989 Sb.
3) Rámcové xxxxxxxxxx Xxxx 2004/757/XXX ze xxx 25. xxxxx 2004, xxxxxx xx xxxxxxx minimální xxxxxxxxxx xxxxxxxx xx xxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx xxxx x xxxxxx x oblasti xxxxxxxxxxxx xxxxxxx s xxxxxxx.
Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2017/2103 xx xxx 15. xxxxxxxxx 2017, xxxxxx xx xxxx xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX x cílem xxxxxxxx xx definice xxxxx xxxx xxxxxxxxxxxxx xxxxx x zrušuje xxxxxxxxxx Xxxx 2005/387/XXX.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (XX) 2019/369 xx xxx 13. xxxxxxxx 2018, kterou xx xxxx příloha xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX, xxxxx xxx o xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxx do xxxxxxxx xxxxx.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (EU) 2020/1687 xx dne 2. xxxx 2020, xxxxxx se xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX, pokud xxx o xxxxxxxx xxxx xxxxxxxxxxxxx xxxxx X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1 X-xxxxxxxxxxxx-1-xxxxxxxxx (xxxxxxxxxxxx) xx xxxxxxxx xxxxx.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (XX) 2021/802 xx xxx 12. xxxxxx 2021, kterou xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Rady 2004/757/XXX, xxxxx xxx x zahrnutí xxxxxx xxxxxxxxxxxxxxx xxxxx methyl 3,3-xxxxxxxx-2-{[1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx} butanoát (MDMB-4en-PINACA) x methyl 2-{[1-(4-fluorobutyl)-1H-indol-3-karbonyl]amino}-3,3-dimethylbutanoát (4X-XXXX-XXXX) do xxxxxxxx xxxxx.
 
                    